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With improved medical and surgical care, kidney transplant recipients (KTR) are living longer than 
ever before. When KTR require acute care (AC) surgery for non-transplant issues, it is unclear who 
should manage this unique population and what specific risks KTR face during the course of surgical 
care.  
To elucidate surgeon perspectives on acute care surgical management of transplant recipients, we 
designed and nationally administered a survey to transplant and AC surgeons. We then investigated 
the differences in mortality, morbidity, length of stay (LOS) and cost between KTR and non-
transplant recipients (non-KTR) undergoing appendectomy, cholecystectomy and colorectal 
resection as a retrospective cohort study using data from the National Inpatient Sample and adjusting 
for patient and hospital level factors.   
There were 230 survey participants who were AC surgeons (response rate 14%) and 204 from 
transplant surgeons (response rate 20%). Both AC and transplant surgeons (78% and 100%) agreed 
that KTR care would be better at transplant centers, and that KTR requiring urgent surgery should 
be transferred to a transplant center if possible (80.2% and 87.2%). However, AC surgeons with 
more years of practice were less likely to transfer KTR to a transplant center (p = 0.03). In the 
national cohort study of appendectomy, complications were similar among KTR and non-KTR, 
while LOS and costs were greater for KTR (LOS ratio 1.191.311.45; cost ratio 1.111.171.26). For 
cholecystectomy, KTR had higher mortality (2.7% vs 1.2%, p<0.001), morbidity (18.8% vs 13.9%, 
p<0.001; aOR 1.30 95%CI 1.12-1.51), LOS and costs (LOS ratio 1.171.231.28 1.23; cost ratio 
1.081.131.171.13). For colorectal resection, KTR had higher mortality (11.1 vs 4.3%, p <0.001; aOR 
2.683.594.81), morbidity (38.5 vs 31.5%, p =0.001; aOR 1.081.301.56), LOS and costs (LOS ratio 
1.421.531.65; cost ratio 1.421.541.63). 
Both AC and transplant surgeons recommend managing KTR at transplant centers. While KTR did 
not have higher mortality or morbidity following appendectomy, they had higher mortality, 
iii 
 
morbidity, longer LOS and greater cost following cholecystectomy and colorectal resection. Surgeons 
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Chapter 1. Introduction 
 
Nearly 400,000 patients have had kidney transplants since 1988, and with innovations in 
immunosuppressive and medical therapy, kidney transplant recipients (KTR) are living longer than 
ever with their transplanted organs.1–3 As these unique patients continue to live longer with 
functioning allografts, surgeons will see more KTR presenting with acute surgical conditions such as 
appendicitis and cholecystitis that require surgical intervention. Despite the growing number of 
transplant recipients and the potentially compounding effect of transplant history on acute care 
surgery outcomes, there is very little data to support decision making for these patients.  
 
Appendicitis is one of the most common surgical diseases in the United States, with a lifetime risk of 
6.7% in females and 8.6% in males.4 While post-appendectomy morbidity is low (4.1-6.4%) and post-
operative length of stay (LOS) is short (0-2.4 days) in the general population, the cumulative effect of 
previous kidney transplant and appendectomy on post-operative morbidity, LOS, and hospital-
associated cost has not been characterized.5,6 Additionally, the surgical approach for appendectomy 
has changed over time. Currently, laparoscopic appendectomy is the standard approach, with 76% of 
appendectomies performed laparoscopically as of 2010.6 However, controversy still exists regarding 
the safety and appropriateness of the laparoscopic approach for transplant recipients.  While a recent 
review advocated for the broader application of laparoscopy in KTR, it only cited a 2-patient case 
series of KTR safely undergoing appendectomy.7,8  The lack of literature supporting the safety of 
laparoscopic appendectomy among KTR may inhibit more widespread utilization of this approach, 
which might otherwise provide a safer and lower-cost option for these patients.5 
 
Cholecystectomy is also one of the most common general surgery procedures performed in the 
United States, with more than 400,000 cases performed every year.9,10 Post-cholecystectomy 
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morbidity and mortality are low with an average hospital LOS of two days.11–13 KTR, however, are at 
higher risk of developing gallstones and biliary disease than the general population due to their 
history of renal failure and immunosuppressive medications such as calcineurin inhibitors.14,15 This 
additional risk combined with improved post-transplant survival has led to a higher incidence of 
cholecystectomy in the kidney transplant population in recent years.16 Despite this, the potential 
cumulative effect of transplant history on cholecystectomy outcomes remains uncharacterized.9,14  
 
Finally, more than 300,000 colectomies are performed annually in the United States for a variety of 
pathologies, including diverticulitis and cancer.17,18 Transplant recipients have 2.6-fold higher 
incidence of colorectal cancer than non-transplant recipients19, with a 5-year cumulative incidence 
rate of 0.5%.20 Kidney transplant recipients also have a higher incidence of acute diverticulitis than 
the general population (0.94% vs 0.02%).21 Because transplant recipients are at increased risk of these 
diseases, they are more likely to require colorectal resections as compared to the general population. 
Despite their increased need for acute care surgery intervention, it is unclear who should perform 
these non-transplant acute care surgeries and where this care should be delivered. 
 
Surgeons continue to express concerns about increased risk of morbidity, mortality, longer LOS, and 
higher costs of care for transplant recipients, although not all of these concerns are necessarily 
evidence based. Studies of cardiac and lung transplant recipients undergoing cholecystectomy and 
hernia repair suggest that mortality and morbidity are not significantly elevated in this population and 
that transplant status should not be prohibitive of pursuing surgical treatment.22,23  Other studies 
have reported that post-operative outcomes for solid organ transplant recipients following general 
surgical procedures are worse than the general population, with a recent review citing up to 32.7% 
mortality and 17.5% morbidity for emergency abdominal surgery, in comparison to 5.5% mortality 
and 9% morbidity in non-transplant recipients.6,9 However, many transplant physicians feel that 
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morbidity, LOS and cost might be mitigated if transplant recipients receive their surgical care at 
transplant centers.24,25   
 
The argument that transplant recipients incur longer lengths of stay and higher costs after general 
surgery remains controversial as well. Taghavi et al. demonstrated that solid-organ transplant 
recipients remained in the hospital for 4-8 days following cholecystectomy as compared to a median 
of one day among non-transplant recipients.11,22 In a review, De’Angelis et al. reported a median LOS 
of 22.2 days following colorectal resection for kidney transplant recipients as compared to a national 
average of 9.3 days.9,26 To date, no studies have investigated cost differences in surgical care for 
transplant recipients as compared to non-transplant recipients for non-transplant surgical 
intervention, and none of the studies addressing length of stay discuss outcomes by center type.27–29  
 
Book chapters discussing non-transplant surgery in transplant recipients warn that complications are 
higher and that these medically complex patients should be treated at transplant centers to avoid 
undue complications.24,30,31 These references primarily serve to guide preoperative optimization of 
transplant recipients and to caution general surgeons from underestimating the risks of treating this 
unique population. However, there is no substantial evidence that care for non-transplant related 
surgeries at transplant centers improves outcomes. There is limited data to support that these 
patients will benefit from transfer, and these studies focus on medication adherence and graft 
rejection, rather than on surgical outcomes directly.3,32,33 There are currently no studies that 
document perspectives of acute care surgeons on the treatment of transplant recipients. Additionally, 
transplant surgeons, who are board certified in general surgery, have practices that span acute care 
surgery in transplant recipients.34 To what degree transplant surgeons feel comfortable performing 
acute care surgery on transplant recipients is also unknown, yet might greatly inform practice and 
potential transfer of these patients.35 A previously published survey of surgeon members of the 
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American Society of Transplant Surgeons collected responses from 171 transplant surgeons, and 
found that 80% perform general surgery cases with a median of 55 general surgery cases per year.34 
Most importantly, transplant recipients may benefit more than non-transplant patients by undergoing 
surgery at a transplant center, and this should be investigated.  
 
An improved understanding of mortality, morbidity, length of stay, and associated cost of treating 
kidney transplant recipients at transplant centers and at non-transplant centers is critical for peri-
operative planning and risk stratification within a population of unique and potentially higher-risk 
patients. As such, this dissertation seeks to address these research questions in order to improve 
decision making for physicians and their previously transplanted patients.  
 
In Chapter 2, we used a nationally distributed focus-group-tested survey to delineate acute care 
surgeon and transplant surgeon perspectives and practices with respect to previous transplant 
recipients. We hypothesized that acute care surgeons in non-transplant centers would rather transfer 
transplant recipients, even for urgent surgical needs to transplant centers, believing that transplant 
centers provide better care and superior outcomes in terms of length of stay and cost. We 
hypothesized that acute care surgeons with more experience (higher case volume and more years in 
practice) would feel more comfortable operating on transplant recipients and would be less inclined 
to transfer them to transplant surgeons for surgery. Additionally, we hypothesized that transplant 
surgeons would desire to perform acute care surgery on transplant recipients themselves, and would 
support transfer of these unique patients to transplant centers.  
 
In Chapters 3-5, we investigated differences in mortality, morbidity, length of stay, and cost between 
kidney transplant recipients and non-transplant patients undergoing acute care surgical procedures. 
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We hypothesized that kidney transplant recipients would have higher mortality and morbidity than 
non-transplant recipients following acute care surgery. We anticipated a longer LOS and a higher cost 
for kidney transplant recipients. We hypothesized that outcomes for kidney transplant centers would 
vary by the center type. Specifically, we expected that among kidney transplant recipients, those who 
had acute care surgery at transplant centers would have better outcomes than at non-transplant 
centers. To investigate these outcomes, we studied a large population of patients undergoing 
appendectomy, cholecystectomy, and colectomy using the National Inpatient Sample. In order to 
document differences in outcomes for kidney transplant recipients treated at transplant centers 
compared to those treated at non-transplant centers, we evaluated for effect measure modification by 





Chapter 2. Acute Care Surgery for Transplant Recipients: A Cross-
sectional Survey of Surgeon Perspectives and Practices 
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Kent Stevens MD (1), Elliott Haut MD PhD (1), Dorry L. Segev MD PhD (1,2), Jacqueline 
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Background. There are a growing number of transplant recipients, who with innovations in medical 
and surgical therapy, are living longer than ever before. When these recipients require acute care 
surgery for non-transplant related issues, it is unclear who should operate on and manage this unique 
population. We hypothesized that while both acute care and transplant surgeons would feel 
comfortable operating on this unique patient population, both would believe transplant centers 
provide superior care.  
Methods. To characterize surgeon perspectives on the management of transplant recipients for non-
transplant related issues, we conducted a national survey of transplant surgeons and acute care 
surgeons. The survey instrument was based on interviews with key informants practicing at 
transplant and non-transplant centers and was distributed by email. Surgeon and center specific 
demographics were collected; acute care and transplant surgeon preferences were compared using 𝜒2 
tests and multivariable logistic regression. 
Results. We obtained 230 responses from acute care (AC) surgeons and 204 from transplant 
surgeons (response rates 14% and 20%, respectively). AC surgeons and transplant surgeons agreed 
that care would be better at transplant centers (78% and 100%), and that transplant recipients 
requiring AC surgery should be transferred to a transplant center if possible (80.2% and 87.2%). AC 
surgeons felt comfortable operating (97.5%) and performing laparoscopic procedures (94.0%) on 
transplant recipients. AC surgeons with more years of practice were less likely to transfer urgent cases 
to a transplant center than those with fewer years (p = 0.03). AC surgeons cited transplant 
medication use (steroid or other) as the most important underlying cause of increased surgical 
complications for transplant recipients. Transplant surgeons felt it was their responsibility to perform 
AC surgery on transplant recipients (67.3%), but less so if patient underwent transplant at a different 
institution (26.5%).  Transplant surgeons were less likely to transfer patients to an AC surgeon for an 
elective case (aOR 0.14 95%CI 0.05-0.40) or urgent case (aOR 0.23 95%CI 0.13-0.60) if they took 
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general surgery call. Transplant surgeons cited poor transplanted organ resiliency as the most 
important underlying cause of increased surgical complications for transplant recipients.  
Conclusions. AC surgeons and transplant surgeons feel comfortable performing laparoscopic or 
open acute care surgery on transplant recipients, and recommend treating transplant recipients at 
transplant centers despite the lack of evidence to support this. Elucidating these common goals and 





Nearly 400,000 patients have had kidney transplants since 1988, and with innovations in 
immunosuppressive and medical therapy, they are living longer than ever with their transplanted 
organs.1–3 As in the general population, these unique patients are at risk of acute surgical conditions, 
such as appendicitis, and will require surgical treatment. Kidney transplant recipients are at an 
increased risk of developing gallstones, diverticulitis, and colorectal cancer, which could all result in 
an increased need for acute care surgical intervention compared to the general population.14,20,21 
Despite this need, it is unclear who should perform these non-transplant acute care surgeries and 
where this care should be delivered.  
 
Anecdotal evidence suggests that community surgeons feel compelled to transfer transplant 
recipients to transplant centers for their care. Book chapters discussing non-transplant surgery in 
transplant recipients warn that complications are higher and that these patients should be treated at 
transplant centers to avoid undue complications.24,30,31 There is limited data to support that these 
patients will benefit from transfer, and the available studies focus on medication adherence and graft 
rejection, rather than surgical outcomes.3,32,33 However, there are currently no studies that document 
perspectives of acute care surgeons on the treatment of transplant recipients. Additionally, transplant 
surgeons, who are board certified in general surgery, have practices that span acute care surgery in 
transplant recipients.34 To what degree transplant surgeons feel comfortable performing acute care 
surgery on transplant recipients is also unknown.  
 
To investigate these issues, we designed and distributed a survey to acute care and transplant 
surgeons nationally. We queried their individual perspectives and practice patterns for transplant 
recipients, and compared responses from acute care surgeons practicing at non-transplant centers, 





Study design and population 
We conducted a cross-sectional survey of acute care (AC) and transplant surgeons regarding their 
perceptions and practices when treating transplant recipients who require acute care surgery 
intervention. We performed a pilot survey of acute care and transplant surgeons at our institution 
prior to distributing the survey nationally to transplant and acute care surgeons. Transplant surgeon 
members of the American Society of Transplant Surgeons (ASTS) comprised the transplant surgeon 
study population. Acute care surgeon members of the Eastern Association for the Surgery of Trauma 
(EAST) comprised the acute care surgeon population.  
 
Survey development and content 
The survey tool was developed following key informant interviews with two acute care surgeons 
from transplant centers (11/15/2016 and 11/16/2016), one acute care surgeon from a non-
transplant center (11/18/2016) and one transplant surgeon (12/6/2016).  The questionnaire was 
drafted using the domains identified in the interviews. Key informants then reviewed the 
questionnaire to check for clinical accuracy and applicability. We used the Qualtrics survey interface 
to design and administer the survey tool.  
 
The survey instrument was divided into three sections: demographic information (6 items), individual 
practice information (ranging between 5 and 8 items), and “reasonable standard of care” information 
(between 20 and 25 items). Individual items were designed for and targeted towards one of three 
specific participant groups: acute care surgeons at non-transplant centers, acute care surgeons at 
transplant centers, and transplant surgeons. Question types varied from multiple choice to binary 
11 
 
yes/no, with one free text question. The final section of the survey contained five scenarios regarding 
transplant recipients presenting to non-transplant centers, and surgeons were asked to rank scenarios 
on a 1-5 Likert scale, ranging from 1 “definitely treat at non-transplant center” to  3 “transfer if 
possible to a transplant center” to 5 “definitely transfer to a transplant center”. The questions posed 
to respondents varied based on their responses to demographic and individual practice information 
to ensure that questions were pertinent to their respective participant group. For example, a question 
regarding a respondent’s distance away from the nearest transplant center only pertained to acute 
care surgeons practicing at non-transplant centers, and the Qualtrics interface allowed us to target 
this question towards that subpopulation. Please see Appendix A for the full questionnaire. This 
anonymous survey was considered exempt and acknowledged by the Johns Hopkins Hospital IRB 
(IRB00127443, 2/24/2017).  
 
Pilot administration 
Prior to national dissemination, we distributed the pilot questionnaire to surgical faculty at Johns 
Hopkins Hospital via the faculty list serve, which included general surgeons practicing at both non-
transplant centers and transplant centers, as well as transplant surgeons, on 6/22/2017, with two 
reminder emails sent at weekly intervals. A total of 137 surgeons received a link to the survey, and 30 
responses were collected (22%). Three surveys were blank or contained only demographic data, and 
were excluded. A total of 27 surveys were available for analysis (20%), of which 15 were completed 
by surgeons who did not take acute care surgery call or who were not transplant surgeons. In the 
pilot interface, only surgeons who responded “yes” to taking general surgery call or those who were 
transplant surgeons were eligible to complete the whole survey. This narrowed our pilot analysis to 
12 responses (9%). Following feedback from survey respondents and department faculty, the final, 
nationally disseminated questionnaire allowed any respondent to complete the entire questionnaire, 
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whether or not they took general surgery call, allowing for further comparisons between surgeon and 
center subgroups.  
 
Study population 
Transplant surgeon members of the American Society of Transplant Surgery (ASTS) comprised the 
transplant surgeon study population. We accessed an online registry of ASTS members and cross 
referenced each entry using searches to exclude non-surgeon transplant providers, resulting in a list 
of 984 transplant surgeons. Acute care surgeon members of the Eastern Association for the Surgery 
of Trauma (EAST) comprised the acute care surgeon population. Permission to distribute the survey 
tool via the EAST membership list of trauma and acute care surgeons was sought through a formal 
application process. The survey was reviewed by the EAST Research-Scholarship committee and 
approved for distribution. The list of 1671 active, provisional, and senior members was obtained. In 
total, 984 transplant surgeons and 1671 acute care surgeons fulfilled criteria for study inclusion at the 
respective dates of distribution.  
Survey administration 
An IRB approved email describing the study was sent to all eligible participants. Respondents 
participated via an email link, and anonymous responses were collected. Beginning on 09/05/2017, 
ASTS members were emailed weekly up to five times, and those who elected to participate were not 
included in subsequent reminder mailings. Beginning on 10/05/2017, EAST members were emailed 
every other week up to three times, as specified by EAST survey administration guidelines.  The total 
time from the first survey emailing to the end of the study period, including reminders, was 8 weeks.  
Analytical methods 
We used χ2, Fisher’s exact, and Kruskal-Wallis tests to analyze categorical and continuous variables 
where appropriate. Years in practice and case volume were collected and analyzed as ordinal 
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variables. In the logistic regression models, covariable selection was performed based on clinical 
relevance; model parsimony was investigated using Akaike Information Criterion. Free text answers 
were evaluated for themes and categorized into thematic groups by two independent analysts. For all 
analyses, a two-tailed p-value of < 0.05 was considered statistically significant. Confidence intervals 
are reported as per the method of Louis and Zeger.36 Statistical analysis was performed using Stata 




Of those who received survey invitations, 204 transplant surgeons (21%) and 236 AC surgeons 
(14%) of whom 94 were from non-transplant centers and 136 were from transplant centers. Table 1 
describes practice patterns of respondents across the three surgeon types. There was a relatively even 
distribution across years in practice, with 20-30% of respondents in each category except those “still 
in training”. Case volume was lower for transplant surgeons (73% reported fewer than 200 cases per 
year) compared to AC surgeons (49.3% at transplant centers and 52.2% at non-transplant centers 
reported fewer than 200 cases per year, p<0.001). AC surgeons at non-transplant centers had the 
highest case volume (22% reporting more than 300 cases per year) and were more likely to practice in 
community settings (59.5%, p <0.001) and in rural areas (11.7%, p<0.001). The majority of 
transplant surgeons and AC surgeons at transplant centers reported practicing at academic/teaching 
hospitals (82.4% and 93.4% respectively) and in urban settings (84.2% and 86%).  Only 11.7% of 
transplant surgeons reported taking general surgery call, compared to 84.4% and 97.8% of AC 
surgeons at transplant and non-transplant centers, respectively.  
Practice Specific Responses 
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Transplant surgeons reported their most advanced AC surgery case type was appendectomy or 
cholecystectomy (basic) 27.3% of the time; in contrast, only 1.1% of AC surgeons at transplant 
centers and 0% at non-transplant centers listed appendectomy and cholecystectomy as their most 
advanced ACS case type. Among transplant surgeons 44.2% reported being comfortable performing 
gastrectomy or colectomy (advanced) AC surgery cases. AC surgeons reported their most advanced 
surgery case type was colectomy or gastrectomy (advanced) 87.3% and 80.7% of the time at 
transplant and non-transplant centers respectively. 76.5% of transplant surgeons reported feeling 
comfortable with laparoscopy compared to >95% of AC surgeons (p <0.001, Table 1.) 
 
The vast majority of all respondents reported performing acute care surgery on transplant recipients 
in their practice (93.5-97.5%, Table 2). AC surgeons reported performed laparoscopy on transplant 
recipients with more frequency than transplant surgeons (87% at non-transplant centers, 94% at 
transplant centers vs 77% of transplant surgeons, p<0.001).  
 
Surgeon Perspectives at Transplant Centers 
Surgeons at transplant centers (transplant surgeons and AC surgeons) responded “yes” more 
frequently to “Do transplant recipients (TR) get better care following general surgery procedures if 
they are cared for at transplant centers?” (95.9%, 89.7%) than AC surgeons at non-transplant centers 
(71.7%, p<0.001). Surgeons at transplant centers also felt more strongly that “Transplant recipients 
should be transferred to transplant centers for urgent/emergent general surgery needs whenever 
possible.” (87.2%, 80.2% vs 57.6%, p<0.001, Table 2). 
 
Sixty-seven percent of transplant surgeon respondents believed it was their responsibility to perform 
AC surgery on TR, whereas 77.4% of AC surgeons believed it was an AC surgeon’s responsibility (p 
15 
 
<0.001, Table 3a). When asked about transferring a TR to the AC surgery team, 68% of transplant 
surgeons responded they would transfer to AC surgeons for elective cases, and 31% would transfer 
to AC surgeons for urgent/emergent cases (Table 3b). Among transplant surgeons who would not 
transfer to an AC surgeon for urgent/emergent surgery, 65.4% reported they would rarely or never 
request intraoperative help from AC surgeons. When asked about transferring a TR to the transplant 
surgery team, 35% of AC surgeons responded they would transfer to a transplant surgeon for elective 
surgery, and 26% would transfer to transplant surgeons for urgent/emergent surgery. The majority of 
AC surgeons reported they would request intraoperative assistance from a transplant surgeon in 
elective cases (16% would always, 15% most of the time and 27% sometimes, total of 58%), and for 
urgent/emergent cases (17% would always, 26% most of the time and 19% sometimes, total of 62%, Table 
3b). 
 
In a multivariable model, AC surgeons were more likely to report transferring elective cases to 
transplant surgeons if they had higher case volume (aOR 0.310.490.79), after adjustment for years in 
practice, hospital setting, and hospital type (Table 5). AC surgeons were less likely to transfer urgent 
cases to transplant surgeons if they had more years in practice (aOR 0.440.650.95). Transplant surgeons 
were less likely to transfer elective cases to AC surgeons if they had higher case volume (aOR 
0.430.620.91) or if they take general surgery call (aOR 0.050.140.40), adjusting for years in practice and 
comfort with laparoscopy on TR. Transplant surgeons were less likely to transfer urgent cases to AC 
surgeons if they reported comfort performing laparoscopy on TR (aOR 0.130.280.60) or if they take 
general surgery call (aOR 0.050.231.06), although the latter was only marginally significant.  
 
Perspectives of surgeons practicing at non-transplant centers 
AC surgeons practicing at non-transplant centers felt they could easily (78%) or with some difficulty 
(22%) contact a transplant center or transplant surgeon for help with a transplant recipient. Among 
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AC surgeons at non-transplant centers, 41% practiced within 10 miles of a transplant center, but 
33% practiced >50 miles from the nearest transplant center (Table 4). When asked about transferring 
TR to transplant centers, 61% would do so for elective operations and 35% would do so for 
urgent/emergent operations (Table 4.) Distance from transplant center was not associated with 
tendency to transfer TR (p=0.4). 
 
Who should be transferred? 
There was a linear trend in willingness to transfer TR, such that the longer time post-transplant the 
less likely the surgeon would transfer the TR to a transplant center. Surgeons reported the lowest 
need to transfer TR who were over five years out from transplantation (Figure). Surgeons reported 
the highest potential need to transfer TR with acute liver failure (Figure). Despite the linear 
relationship reported by each group, the three surgeon groups differed significantly for each scenario, 
such that transplant surgeons felt more strongly that each patient type should be transferred to 
transplant team or center (p<0.001, Table 6). 
 
AC surgeons provided 99 free-text responses when asked what the number one reason would be to 
transfer a TR requiring acute care surgery to a transplant team or transplant center. The five most 
prominent themes were safety of the transplanted organ/graft, continuity of care between transplant 
patient and transplant team, management of perioperative medications, medical liability, and patient 
preference. 
 
Transplant center expectations 
Very few surgeons reported having hospital policies indicating who should perform acute care 
surgery on transplant recipients (16.8% of transplant surgeons, 8.6% AC surgeons at transplant 
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centers, and 0% of AC surgeons at non-transplant centers). When asked about cost of care for TR 
following acute care surgery, responses were similar across all surgeon types, with a large proportion 
believing the cost would be the same at transplant and non-transplant centers (p=0.3, Table 2). 
Regarding length of stay (LOS), surgeons felt that LOS would be longer at non-transplant centers or 
the same regardless of center type (p=0.2, Table 2). 
 
Surgeon concerns  
Responses were varied between surgeons on what they considered the most concerning feature of 
performing AC surgery on TR (p <0.001, Table 7). Transplant surgeons reported that management 
of postoperative medications (38.5%), higher risk of other complications (19.3%) and anatomical 
differences (17.2%) were the most concerning. AC surgeons at transplant centers reported that 
management of postoperative medications (45.9%), higher risk of other complications (22.5%) and 
wound healing complications (18.0%) were the most concerning. AC surgeons at non-transplant 
centers reported that management of postoperative medications (58.4%) and the risk of renal failure 
(14.6%) were the most concerning.  
 
AC surgeons reported that non-steroid transplant medication use was the most important cause of 
increased complications (41.8% and 39.3% at transplant and non-transplant centers, respectively) 
with steroid use a close second (34.8% and 39.1%). Transplant surgeons most frequently reported 
that “transplanted organs being ‘less resilient to insult’ ” was the most important cause of increased 
complications in transplant recipients (35.8%), and non-steroid transplant medication use was the 





We performed a national survey of transplant and acute care surgeons to elicit perspectives and 
practice patterns of surgeons across the United States and characterize transplant recipient 
management. We found that 67% of transplant surgeons felt responsible for acute care surgery in 
transplant recipients and 69% would perform the operation themselves if urgent or emergent. 
However, transplant surgeons also reported feeling less comfortable than acute care surgeons 
performing laparoscopic surgery on transplant recipients (77% vs 94%, p<0.001) and relatively few 
(12%) routinely take general surgery call. Additionally, transplant surgeons felt much less strongly 
that that they should operate on transplant recipients who received their transplant elsewhere, with 
only 27% indicating that transplant surgeons should operate on this group. These findings, taken 
together, suggest that although transplant surgeons are willing to provide acute care surgery for 
transplant recipients, it may be more appropriate for AC surgeons to perform these cases, particularly 
if laparoscopy is indicated or if the patient and transplant surgeon do not have a pre-existing 
relationship. 
 
A previously published survey of surgeon members of the American Society of Transplant Surgeons 
collected responses from 171 transplant surgeons, and found that 80% perform general surgery cases 
with a median of 55 cases per year.34 This is a slightly higher percentage than we found, particularly 
given that we found only 31% of transplant surgeons in our study reported performing elective 
general surgery cases on transplant recipients. It is important, however, to distinguish that transplant 
surgeons might be performing general surgery on non-transplant recipients. 
 
In contrast to transplant surgeons, fewer AC surgeons would transfer transplant recipients needing 
urgent/emergent surgery (26%), but more than half would ask for help from transplant surgeons. As 
we found, AC surgeons report higher case volumes (48% with 200+ cases per  year) than transplant 
surgeons (27%), and AC surgeons with higher case volumes and more years in practice were less 
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likely to transfer patients to transplant teams for elective and urgent cases, respectively. Recent 
studies have demonstrated improved outcomes of patients when treated by high volume surgeons for 
emergency general surgery, suggesting that surgeon experience and familiarity with the procedures 
and setting contribute to good outcomes.37,38 
 
The vast majority of both acute care surgeons at transplant centers (89.7%) and transplant surgeons 
(95.9%) agreed that transplant recipients get better care at transplant centers. Prior to the 
performance of this survey, this sentiment was documented only anecdotally in book chapters.24,30,31 
These chapters primarily served to guide preoperative optimization of transplant recipients and to 
caution general surgeons from underestimating the risks of treating this unique populations. There 
are studies that demonstrate the benefits of pursuing future care at transplant centers, most 
importantly to maintain optimal transplant medication compliance.32,33 Accordingly, this study found 
that the primary concern for 58.4% of AC surgeons at non-transplant centers is management of 
postoperative medications.  
 
However, there is no substantial evidence that care at transplant centers for prior transplant 
recipients with non-transplant related surgical issues improves outcomes. Despite our findings that 
nearly all of the respondents surveyed would recommend transfer of transplant recipients who are <5 
years out from their transplant date to a transplant center for management of an acute care surgery 
issue, there is no data to support that these patients will benefit from transfer. In a recent study of 
emergency general surgery outcomes at teaching vs non-teaching hospitals, Zafar et al found that 
there was no clinical difference in mortality or morbidity between patients treated at the different 
hospital types.39 Although teaching hospital status is not a perfect surrogate for transplant center, 
82% of transplant surgeon respondents in our study reported working at a teaching hospital, and the 
findings of the Zafar et al study may be generalizable to patients at transplant centers. Most 
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importantly, transplant recipients might benefit more than non-transplant patients from undergoing 
surgery at a transplant center, and this should be investigated.  
 
The majority of all surgeons surveyed believed that hospital cost would be the same for care 
regardless of transplant center status. Surgeons who work at transplant centers believed the length of 
stay would be shorter at transplant centers, and AC surgeons at non-transplant centers believed it 
would be the same regardless of center type. Some literature suggests that transplant recipients will 
have longer lengths of stay and higher cost following certain surgical procedures, but none of the 
studies delineate these outcomes by center type.27–29 Documentation of these surgical perceptions 
motivates future study of the potential benefits of treating transplant recipients at transplant centers.  
 
Our study has limitations that merit discussion. Physician surveys are notorious for low response 
rates, and our overall response rate of 16% is lower than would be ideal.40–43 However, our response 
rate is similar to other prominent studies of the surgical workforce, and has a slightly larger number 
of transplant surgeon respondents than a recent survey of the transplant workforce completed by the 
American Society of Transplant Surgeons  (n=171 vs 204).44–47 Although the potential for 
nonresponse bias limits the strengths of our conclusions, it has been demonstrated that higher 
response rate does not prevent significant nonresponse bias.43 This study is also subject to recall bias. 
Acute care surgeons may be more likely to remember operating on transplant recipients if they had 
negative outcomes or difficulties with management. Additionally, selection of the sample population, 
two groups of surgeon members of professional societies, limits generalizability of findings to 
surgeons who would not self-select into these societies. Despite these limitations, this study is unique 
in its documentation of surgeon perspectives on treatment of transplant recipients requiring acute 




In conclusion, in our national survey of acute care and transplant surgeons, we found that both acute 
care and transplant surgeons feel comfortable performing laparoscopic or open acute care surgery on 
transplant recipients, and both recommend treating transplant recipients at transplant centers. 
Elucidating the commonalities and differences in opinions, practice patterns, and recommendations 
encourages the pursuit of confirmatory research to demonstrate clinical differences between 
transplant and non-transplant patients following acute care surgery and to demonstrate potential 
benefits of treatment at transplant centers. These findings will ultimately allow surgeons to make 
informed decisions and provide optimal care for this unique patient population. 
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Table 1. Demographic information of survey respondents, acute care (AC) surgeons at non-
















n (%) p value 
n 94 136 204  
Years in Practice    0.02 
    Still in training 0 (0.0) 6 (4.4) 24 (11.8)  
   <5 24 (25.5) 33 (24.3) 43 (21.1)  
    5-10 20 (21.3) 31 (22.8) 33 (16.2)  
    11-20 24 (25.5) 35 (25.7) 54 (26.5)  
    21+ 26 (27.7) 31 (22.8) 50 (24.5)  
Case Volume    <0.001 
     <100 15 (16.0) 16 (11.8) 55 (27.0)  
     100-200 34 (36.2) 51 (37.5) 94 (46.1)  
     201-300 24 (25.5) 46 (33.8) 36 (17.6)  
     300+ 21 (22.3) 23 (16.9) 19 (9.3)  
Hospital Type    <0.001 
     Academic/Teaching 36 (38.3) 127 (93.4) 168 (82.4)  
     Community w Academic Affiliation 38 (40.4) 8 (5.9) 26 (12.7)  
     Community 18 (19.1) 1 (0.7) 10 (4.9)  
Hospital Setting    0.03 
     Urban 57 (60.6) 117 (86.0) 171 (84.2)  
     Suburban 26 (27.7) 15 (11.0) 28 (13.8)  
     Rural 11 (11.7) 4 (2.9) 4 (2.0)  
Take General Surgery Call 91 (97.8) 114 (84.4) 23 (11.7) <0.001 
Most Advanced ACS Case Type 
Performed 
 
  <0.001 
    Basic 1 (1.1) 0 (0.0) 21 (27.3)  
    Intermediate 16 (18.2) 14 (12.7) 22 (28.6)  
    Advanced 71 (80.7) 96 (87.3) 34 (44.2)  
Comfortable with Laparoscopy 90 (96.8) 113 (95.0) 153 (76.5) <0.001 
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Table 2. Perspectives and opinions of acute care (AC) surgeons at non-transplant centers, AC 
surgeons at transplant centers and transplant surgeons on performing acute care (AC) surgery on 
transplant recipients (TR). 
 
 










n (%) p value 
n 94 136 204  
Performed acute care surgery on TR 87 (93.5) 116 (97.5) 193 (97.5) 0.2 
Performed laparoscopy on TR 
recipients 80 (87.0) 109 (94.0) 151 (77.4) <0.001 
TR get better care at transplant centers 66 (71.7) 104 (89.7) 185 (95.9) <0.001 
TR should be transferred when possible 
to transplant centers 53 (57.6) 93 (80.2) 170 (87.2) <0.001 
Hospital has policy about who should 
perform AC surgery on TR 
 
  <0.001 
    Yes 0 (0.0) 10 (8.6) 33 (16.8)  
    No 82 (89.1) 78 (67.2) 133 (67.9)  
    Unsure 10 (10.9) 28 (24.1) 30 (15.3)  
Hospital cost is higher for TR at:    0.3 
     Transplant centers 20 (21.7) 39 (33.9) 49 (26.1)  
     Non-transplant centers 20 (21.7) 25 (21.7) 47 (25.0)  
     The same regardless of center type 52 (56.5) 51 (44.3) 92 (48.9)  
Length of Stay is longer for TR at:    0.2 
     Transplant centers 9 (9.8) 15 (13.0) 27 (14.4)  
     Non-transplant centers 35 (38.0) 53 (46.1) 90 (47.9)  
     The same regardless of center type 48 (52.2) 47 (40.9) 71 (37.8)  
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Table 3a. Opinions regarding performing acute care surgery on transplant recipients (TR) from only 








n (%) p value 
Transplant surgeons should perform ACS on TR 26 (22.6) 132 (67.3) <0.001 
AC surgeons should perform AC surgery on TR 89 (77.4) 64 (32.7) <0.001 
Who should perform AC surgery if TR received 
transplant at different hospital?   <0.001 
     AC surgeons 83 (71.6) 54 (27.6)  
     Transplant surgeons 5 (4.3) 52 (26.5)  





Table 3b. Opinions from surgeons at transplant centers regarding transferring transplant recipients to 
other teams (ACS vs transplant) and asking for assistance from other team (ACS vs transplant) when 
performing acute care surgery on transplant recipients (TR).  
 n (%) 
AC surgeons 136 
   Would refer TR to transplant surgeon for elective general surgery procedure 42 (35.2) 
   Would transfer TR to transplant surgeon for urgent/emergent surgery  31 (26.0) 
   Would ask for intraoperative help from transplant surgeon in elective surgery 
for TR   
         Always 19 (16.0) 
         Most of the time 18 (15.1) 
         Sometimes 32 (26.9) 
         Rarely 38 (31.9) 
         Never 12 (10.0) 
   Would ask for intraoperative help from transplant surgeon in urgent/   
emergent surgery for TR  
         Always 20 (16.8) 
         Most of the time 31 (26.0) 
         Sometimes 23 (19.3) 
         Rarely 36 (30.25) 
         Never 9 (7.5) 
  
Transplant surgeons  204 
   Would refer TR to AC surgeon for elective general surgery procedure  
         Yes, in all cases 25 (12.5) 
         Yes, but only complex procedures 111 (55.5) 
         No 64 (32) 
   Would transfer TR to AC surgeon for urgent/emergent surgery  62 (31) 
   Would ask for intraoperative help from AC surgeon in urgent/emergent  
   surgery for TR  
         Always 0 (0.0) 
         Most of the time 6 (4.4) 
         Sometimes 41 (30.1) 
         Rarely 62 (45.6) 










AC surgeons at non-
transplant centers (n=94)  
n (%) 
Distance to nearest transplant center  
        <10 miles 39 (41) 
        10-19 miles 11 (12) 
        20-49 miles 13 (14) 
        50-100 miles 16 (17) 
        >100 miles 15 (16) 
Do you have the ability to contact transplant center or transplant 
surgeon for help?  
        yes, easily 72 (78) 
        yes, but it would be difficult 20 (22) 
        no 0 (0.0) 
Would transfer TR needing ELECTIVE operation? 57 (61) 
Would transfer TR needing URGENT/EMERGENT operation? 33 (35) 
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Table 5. Multivariable logistic regression models for acute care and transplant surgeons regarding 
transfer of transplant recipients for elective or urgent/emergent surgical needs. Years in practice and 
case volume treated as ordinal variables; take general surgery call and performing laparoscopy on TR 
were binary variables. 
 OR 95% CI p value 
AC Surgeons elective transfer    
  years in practice^ 0.85 0.60 - 1.20 0.4 
  case volume* 0.50 0.31 - 0.81 0.005 
  hospital setting 0.85 0.30 - 2.40 0.7 
       rural ref ref ref 
       suburban 0.92 0.07 - 12.56 0.9 
       urban 1.18 0.11 - 12.78 0.9 
AC Surgeons urgent transfer    
  years in practice^ 0.66 0.44 - 0.96 0.03 
  case volume* 0.67 0.40 - 1.08 0.12 
  hospital setting    
      rural ref ref ref 
      suburban 0.37 0.02 - 6.09 0.5 
      urban 0.69 0.06 - 7.98 0.8 
    
Transplant Surgeons elective transfer    
  years in practice^ 1.07 0.82-1.39 0.6 
  case volume* 0.62 0.43-0.91 0.015 
  take general surgery call 0.14 0.05 - 0.40 <0.001 
  perform laparoscopy on TR 1.04 0.46 -  2.35 0.9 
Transplant Surgeons urgent transfer    
  years in practice^ 0.79 0.60-1.04 0.09 
  case volume* 0.86 0.58-1.27 0.4 
  take general surgery call 0.23 0.05-1.06 0.06 
  perform laparoscopy on TR 0.28 0.13-0.60 0.049 
^ years in practice treated as ordinal variable: still in training, <5yrs, 5-10yrs, 11-20yrs, >21yrs 
*case volume treated as ordinal variable: <100 cases/year, 100-200 cases/year, 200-300 cases/year, >300 cases per year  
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n 94 136 204  
Most concerning about performing AC 
surgery on TR?     
     Management of postoperative medications 52 (58.4) 51 (45.9) 74 (38.5)  
     Wound healing complications 13 (14.6) 20 (18.0) 14 (7.3)  
     Higher risk of other complications 9 (10.1) 25 (22.5) 37 (19.3)  
     Anatomical differences 4 (4.5) 7 (6.3) 33 (17.2) <0.001 
     Increased risk of mortality 3 (3.4) 2 (1.8) 15 (7.8)  
     Risk of renal failure 3 (3.4) 2 (1.8) 6 (3.1)  
     Other 5 (5.6) 4 (3.6) 13 (6.8)  
     
Most important cause of increased 
complications? 
 
  <0.001 
     Steroid use 31 (34.8) 43 (39.1) 33 (17.4)  
     Other transplant medication use 35 (39.3) 46 (41.8) 65 (34.2)  
     Transplanted organs less resilient to insult 
    (acute renal failure, acute liver failure) 20 (22.5) 15 (13.6) 68 (35.8)  
     History of organ failure causing irreparable 
    damage to tissues 2 (2.2) 1 (0.9) 11 (5.8)  
     Other 1 (1.1) 5 (4.5) 13 (6.8)  
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Table 7. Acute care (AC) surgeons and transplant surgeons describe what they feel the appropriate 
treatment would be for a transplant recipient who presents with an urgent/emergent surgery need at 
a non-transplant center. Scale is 1-5, with 1 “definitely treat at non-transplant center”, 3 “transfer if 
possible to a transplant center, but not necessary” and 5 “definitely transfer to a transplant center”. 
Values in table presented as median (IQR). 
 
 AC surgeon at 
non-transplant 
center (n=94) 






>5yrs from transplant 2 (1,3) 3 (2,3) 3 (3,3) <0.001 
1-5yrs from transplant 3 (2,3) 3 (3,4) 3 (3,4) <0.001 
<1yr from transplant 3 (3,5) 5 (3,5) 5 (3,5) <0.001 
Acute renal failure 4 (3,5) 5 (4,5) 5 (4,5) <0.001 











Figure. (a) Acute care surgeons at non-transplant centers (b) acute care surgeons at transplant centers 
and (c) transplant surgeons delineate which cases of transplant recipients requiring urgent/emergent 
general surgery should be transferred if presenting at a non-transplant center.  
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Kidney transplant recipients (KTR) have greater morbidity and length of stay (LOS) following certain 
surgical procedures than non-KTR. Given that appendectomy is one of the most common surgical 
procedures, we investigated differences in outcomes between 1336 KTR and 2,640,247 non-KTR 
post-appendectomy at transplant and non-transplant centers in the US from 2000-2011, using NIS 
data and adjusting for patient and hospital level factors. Postoperative complications were identified 
using ICD9 codes. Among KTR, there were no post-appendectomy in-hospital deaths, compared to 
a 0.2% in non-KTR (p=0.5). Overall complications were similar among KTR and non-KTR (17.0% 
vs 11.6%; aOR 0.771.121.61). LOS and costs were greater for KTR compared to non-KTR (LOS ratio 
1.191.311.45; cost ratio 1.111.171.26). Only 44.8% of KTR had laparoscopic approach compared to 54.5% 
of non-KTR, but had similar complication rates (10.6 vs 8.7%, p 0.5). When treated at transplant 
centers, KTR had similar complications (aOR 0.440.791.43), but longer LOS (ratio 1.211.371.55) and 
greater hospital-associated costs (ratio 1.191.291.41) than non-KTR. Conversely, at non-transplant 
centers, KTR and non-KTR had similar complications (aOR 0.751.232.0), LOS (ratio 0.840.961.09), and 
cost (ratio 0.931.011.10).  Contrary to results from other procedures, KTR did not constitute a high-risk 





Appendicitis is one of the most common surgical diseases in the United States, with a lifetime risk of 
6.7% in females and 8.6% in males.4 As in the general population, kidney transplant recipients (KTR) 
are at risk of requiring appendectomy, although the incidence of appendicitis in KTR has not been 
well documented outside of small case series.9,48–54 Further, while post-appendectomy morbidity is 
low in the general population (4.1-6.4%) and average post-operative length of stay (LOS) is short (0-
2.4 days), it is unknown if risk, LOS, and thus hospital associated cost is amplified for KTR.5,6 As 
post-transplant survival improves, the number of KTR undergoing appendectomy will likely increase 
proportionally.48,55,56 Therefore, improved understanding of morbidity, length of stay, and associated 
cost in this population is important for peri-operative planning and risk stratification. 
 
Previous studies have reported that post-operative outcomes for solid organ transplant recipients 
following general surgical procedures are worse than the general population, with a recent review 
citing up to 32.7% mortality and 17.5% morbidity for emergency abdominal surgery, in comparison 
to 9% morbidity in non-transplant recipients.6,9 For appendectomy specifically, in the largest case-
series to date that included transplant recipients, there were only 17 appendectomies reported, and 
only 3 of those performed on KTR. In this small population, the documented complication rate was 
surprisingly high at 24%. Additionally, these patients had a mean length of stay of 7 days, compared 
to a median 1 day reported recently for non-transplant patients.6,48 However, many transplant 
providers feel that morbidity, LOS and cost might be mitigated if transplant recipients receive their 
surgical care at transplant centers.24,25   
 
Additionally, the surgical approach for appendectomy has changed over time. Currently, laparoscopic 
appendectomy is the standard approach, with 76% of appendectomies performed laparoscopically as 
of 2010.6 However, controversy still exists regarding the safety and appropriateness of the 
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laparoscopic approach for transplant recipients.  While a recent review discussing the role of 
laparoscopy in transplant recipients advocated for the broader application of laparoscopy in the KTR 
population, it only cited a 2-patient case series of KTR safely undergoing appendectomy.7,8  The lack 
of literature supporting the safety of laparoscopic appendectomy among KTR may be inhibiting 
more widespread utilization of this approach.   
 
To investigate the differences in surgical approach, mortality, morbidity, length of stay and cost 
between KTR and non-KTR undergoing appendectomy, we studied a large population of patients 
undergoing this procedure using the National Inpatient Sample. We also investigated the effect of 
receiving surgical care at a transplant center on approach and post-operative outcomes. 
METHODS 
Study population 
We studied 1336 adult KTR and 2,640,247 non-KTR undergoing appendectomy for appendicitis 
from January 1, 2000 - December 31, 2011. We included all patients who had International 
Classification of Disease, Ninth Revision (ICD-9) procedure codes for laparoscopic or open 
appendectomy and an ICD-9 diagnosis codes for appendicitis. KTR were distinguished from non-
KTR by the presence of ICD-9 diagnosis codes consistent with prior KT. We excluded patients with 
ICD-9 codes indicating a history of other solid or non-solid organ transplants (Appendix B). 
 
Data Source 
Patients were drawn from the Nationwide Inpatient Sample (NIS). Available through the Health 
Care Cost and Utilization Project, the NIS contains data from approximately 7 million hospital stays 
yearly and is made up of a stratified sample of 20% of the non-federal hospitals in the United States. 
The stratified sample is self-weighted to allow for population based estimates.57  Information 
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provided in the NIS includes patient level hospital discharge data such as patient demographics, as 
well as diagnostic and procedural ICD9 codes for the index hospital admission. All study methods 
were approved by the Johns Hopkins Hospital Institutional Review Board.  
 
Patient and Hospital Level Characteristics 
In addition to examining basic demographic information of the study population and surgical 
approach (laparoscopic vs open), the Charlson Comorbidity Index score was calculated for each 
patient.58,59  Hospital characteristics examined included standard NIS categories of location (rural or 
urban), size (small, medium, large), teaching status, and region (north east, mid-west, south, or west). 
In addition, we categorized hospitals as transplant centers or non-transplant centers, where a 
transplant center was defined as a hospital where kidney transplants were performed during the study 
period.  
 
Surgical Outcomes  
Between-group characteristics were compared using chi-squared tests for categorical variables and t-
tests for continuous variables. We defined peri-operative mortality as a death during the index 
hospital admission. Peri-operative morbidity, defined as the occurrence of intraoperative or 
postoperative complications during the index hospital admission, was identified by ICD9 code and 
categorized into system-based groups as established in previous studies (Appendix E).26  Multi-level 
(hierarchical) regression models with random intercepts for each hospital were adjusted for patient-
level (sex, age, African American race, Charlson Comorbidity Index, primary insurance status, and 
surgical approach) and hospital-level factors (location, size, region, teaching status, and transplant 
center status). Complication rates were compared using hierarchical logistic regression. Length of stay 
was examined using hierarchical negative binomial regression. A mixed linear regression model was 
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We investigated whether the association of KTR status with mortality, morbidity, LOS and cost 
varied by treatment at transplant centers vs. non-transplant centers. To evaluate the effect of 
transplant center type on the relationship of KTR and the outcomes above, we created an interaction 
term for KTR status with transplant center status in the regression models described above.  
 
Statistical Analysis 
Confidence intervals are reported as per the method of Louis and Zeger.36 Statistical analysis was 
performed using Stata 14.0 (StataCorp, College Station, Texas). For all analyses, a two-tailed p-value 




Out of 2,641,583 appendectomies performed for appendicitis during the study period, 1336 (0.05%) 
were done in KTR. KTR were older (46.5 vs 40.6 years, p <0.001), more likely to be African 
American (13.6 vs 7.0%, p <0.001), carried a greater comorbidity burden as reflected by a higher 
Charlson Comorbidity Index score (28.6% vs 4% with score ≥2, p <0.001), less likely to be female 
(41.6 vs 47.1%, p 0.07), and less likely to have private insurance (40.6 vs 60.6%, p <0.001).  Nearly 
half (49.6%) of all appendectomies performed on KTR were performed at one of the 222 hospitals 
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identified as transplant centers, whereas only 13% of non-KTR had appendectomies at transplant 
centers (Table 1). 
 
Mortality and Morbidity 
Among KTR, there were no in-hospital deaths following appendectomy, compared to a 0.2% 
incidence in non-KTR (p = 0.5). The crude rate of overall morbidity was 17% for KTR vs 11.6% for 
non-KTR (p = 0.003). Specifically, KTR had higher rates of wound complications (2.5% vs 0.5%, p 
<0.001), infectious complications (4.9% vs 1.7%, p<0.001), and pulmonary complications (4.3% vs 
1.7%, p<0.001) (Table 2). However, after adjusting for patient and hospital level factors, the odds of 
overall morbidity were the same comparing KTR vs non-KTR (aOR 0.771.121.61), although the odds 
of infectious (aOR 1.242.244.08), pulmonary (aOR 1.011.973.81), and mechanical wound complications 
(aOR 1.543.548.09) were still significantly higher for KTR (Table3).  
 
Length of Stay and Cost 
Median length of stay was 3 days in KTR vs 2 days in non-KTR (p <0.001) (Table 2).  After 
adjusting for patient and hospital level characteristics including operative approach, LOS was 1.31-
fold longer for KTR (ratio 1.191.311.45) (Table 3). The average cost for appendectomy was $9,175 for 
KTR and $6,806 for non-KTR (p <0.001). After adjusting for patient and hospital level 
characteristics including operative approach, cost was 1.17-fold higher for KTR (ratio 1.111.171.26).   
 
Surgical Approach 
Appendectomy was performed laparoscopically in 44.8% of KTRs compared to 54.4% of non-KTRs 
(p = 0.002). KTR had significantly more complications following open appendectomy than non-
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KTR (22.4% vs 14.8%, p 0.009), but a similar complication rate following laparoscopic approach 
(10.6% vs 8.7%, p 0.5) (Table 4). Comparing laparoscopic and open approach in KTR only, there 
were significantly fewer wound (0% vs 4.6%, p 0.016) and gastrointestinal (3.2% vs 9.9%, p 0.03) 
complications following laparoscopic approach (Table 5). Compared to non-KTR, KTR had longer 
LOS following both laparoscopic (3 vs 2 days, p <0.001) and open approaches (4 vs 3 days, p 
<0.001). Additionally, cost was higher for KTR following both laparoscopic and open procedures 
when compared to non-KTR (lap $8676 vs $7063, p <0.001; open $9901 vs $6308, p <0.001) (Table 
4). 
 
Transplant Center Status 
After controlling for patient and hospital level factors, KTR were significantly less likely to have a 
laparoscopic procedure at transplant centers than non-KTR (aOR 0.360.550.85 ). When treated at 
transplant centers, KTR had similar morbidity to non-KTR (aOR 0.440.791.43). The association of 
KTR status and length of stay differed among appendectomy patients who were cared for at 
transplant centers compared to non-transplant centers (p<0.001), such that among patients who 
underwent appendectomy at transplant centers, KTR had a 1.36-fold longer LOS compared to non-
KTR. Among those at non-transplant centers, there was no association with KTR status and LOS. 
Additionally, after adjustment, the association of KTR status and hospital cost differed among 
patients who were cared for at transplant centers compared to non-transplant centers (p=0.004), 
such that among patients who underwent appendectomy at transplant centers, KTR had a 1.29-fold 





As the largest national study of kidney transplant recipients undergoing appendectomy, we report 
that KTR have similar mortality (0% vs 0.2%) and overall morbidity (17.0% vs 11.6% in-hospital 
complication rate) as non-KTR. However, KTR are more susceptible to wound (aOR 1.543.548.09), 
infectious (aOR 1.242.244.08), and pulmonary complications (aOR 1.011.973.81) than non-KTR. While 
KTR had significantly longer LOS (ratio 1.37) and higher cost (ratio 1.29) than non-KTR at 
transplant centers, there was no difference in cost or length of stay between KTR and non-KTR at 
non-transplant centers.  
 
We found that 0.05% of appendectomies for appendicitis were performed in KTR. Estimates of the 
incidence of appendectomy in solid organ transplant recipients is similar with reports ranging from 
0.18% to 0.29%.9,48 Our finding of no mortalities in KTR in the NIS was consistent with low 
mortality published in case reports and small series on appendectomy in KTR9,48–51,54. Further, we 
found that there was not a higher complication rate overall for KTR compared to non-KTR 
undergoing appendectomy. The largest single-center series of 17 cases of appendicitis in solid organ 
recipients reported a post-appendectomy complication rate of 24%48, similar to the 17% 
complication rate in KTR in our study. These findings support our hypothesis that although KTR 
have been shown to have higher morbidity and mortality following abdominal surgery55, 
appendectomy does not follow this pattern.2,3  
 
We found that KTR suffered more wound, infectious, and pulmonary complications. This is likely 
influenced by immunosuppression. The impact of immunosuppression on wound healing and 
increased risk of infection is well documented in the literature, particularly in the immediate post-
transplant setting.60–63 Even with modern immunosuppressant regimens including agents such as 
mycophenolate mofetil and tacrolimus, higher rates of wound healing and infectious complications 




We found that KTR have a 1.3-fold longer LOS than non-KTR, with a longer median LOS for both 
laparoscopic appendectomy (KTR 3 days, non-KTR 2 days) and open appendectomy (KTR 4 days, 
non-KTR 3 days) as compared to the median 1 day LOS that Ingraham et al. reported in their study 
of National Surgical Quality Improvement Project (NSQIP) data.6 This might be influenced by the 
use of laparoscopy. We found that the rate of use of laparoscopy was much lower in both KTR 
(44.8%) and non-KTR (54.6%) in our study population compared to 76% laparoscopic 
appendectomy from the NSQIP database.6 Importantly, we found that complication rates for 
laparoscopic appendectomy were not higher than for open appendectomy in KTR, confirming the 
findings of small case series.7,8  This suggests that laparoscopic appendectomy is safe for 
appropriately selected KTR, and although this has been alluded to, this has not been demonstrated 
previously in a qualitative manner. Additionally, we report costs ranging from $6,000-9,000. A prior 
study of total hospital charges for appendectomy, which are higher than costs, reported a range of 
total charges from $20,000 to nearly $39,000.5 While we found that KTR had significantly higher cost 
than non-KTR, we were limited by the nature of our study data in more granular examination of 
costs.  
 
Despite the sentiment expressed in multiple opinion pieces including book chapters and editorials, 
there is no evidence demonstrating improved outcomes for transplant recipients at transplant 
centers.24,30 Indeed, we found no difference in morbidity and mortality between KTRs treated at 
transplant centers and non-transplant centers, however, we did find an increase in length of stay and 
cost at transplant centers. This suggests surgeons are making appropriate choices in who they treat at 
non-transplant centers, and in treating transplant recipients at non-transplant centers, are making 




This study has a few limitations which warrant further discussion. An important limitation is the lack 
of clinical granularity of NIS data. For example, the NIS does not include information on transplant 
laterality or history of multiple previous KTR, therefore we were not able to adjust for these potential 
confounders. Additionally, without more detailed information on the specific costs and events 
occurring during a hospital stay, we are unable to determine the underlying reasons for cost and 
length of stay differences between KTR and non-KTR, and between transplant centers and non-
transplant centers. We were unable to determine whether, for example, those KTR presenting to 
non-transplant centers who were sicker were transferred to transplant centers for care. An additional 
limitation inherent in the design of the NIS is the lack of linkage of patients across multiple 
hospitalizations. The magnitude of the NIS, however, offers an understanding of the national 
outcomes of surgically treated appendicitis in KTR and avoids the bias and limited power associated 
with single-center studies. Finally, there has been a recent surge in non-operative management of 
appendicitis, however we cannot reliably assess this using the NIS, so we limited our study to 
operative management.  It is possible that non-operative management is applied to KTR and non-
KTR differently, and would make operatively managed groups less comparable in terms of disease 
severity.  
 
In conclusion, we report that kidney transplant recipients have similar rates of overall complications 
when compared to non-transplant recipients. Despite similar complication rates, appendectomy at 
transplant centers is associated with longer LOS and higher cost for KTR, but it is unclear what is 
driving these differences. Our findings suggest that if surgeons choose to perform appendectomy at 












Age, mean (SD)  46.5 (13.0)  40.6 (16.6)  <0.001  
Female, %  41.6  46.9  0.07  
African American, %  13.6  6.9  <0.001  
Charlson Comorbidity Index, %      <0.001  
   0  43.8  85.0    
   1  27.6  10.9    
   ≥2  28.6  4.1    
Insurance Status, %      <0.001  
   Public  57.2  21.2    
   Private  40.6  60.7    
   Other  2.3  18.3    
Laparoscopic, %  44.8  54.4  0.002  
Performed at transplant center, %  49.6  13.0  <0.001  
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Table 2. Unadjusted outcomes following appendectomy in kidney transplant recipients (KTR) vs 
non-KTR.  
Outcome  KTR  
(n = 1336)  
Non-KTR  
(n = 2,640,247)  
P value  
Mortality (%)  0  0.2  0.5  
Any Complication (%)  17.0  11.6  0.003  
System specific complications^ (%)        
   Wound  2.5  0.5  <0.001  
   Infection  4.9  1.7  <0.001  
   Pulmonary  4.3  1.7  <0.001  
   Cardiovascular  0  0.5  0.3  
   Genitourinary  1.1  0.6  0.3  
   Gastrointestinal  6.9  7.1  0.9  
   Intraoperative  1.4  0.8  0.2  
LOS, median days (IQR)  3 (2-6)  2 (1-4)  <0.001  






^see Appendix E for breakdown of complications by system    
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Table 3. Adjusted outcomes following appendectomy in kidney transplant recipients (KTR) vs non-
KTR*.  
  
Outcome  KTR vs Non-KTR  95% CI  
Any complications, OR   1.12  0.77-1.61  
System specific complications^, OR      
   Wound  3.54  1.54-8.09  
   Infection  2.24  1.24-4.08  
   Pulmonary  1.97  1.01-3.81  
   Genitourinary  1.18  0.29-4.82  
   Gastrointestinal  0.75  0.44-1.28  
   Intraoperative  1.23  0.39-3.86  
LOS, ratio   1.31  1.19-1.45  
Cost, ratio  1.17  1.11-1.26  
 
*adjusted for age, race, gender, Charlson comorbidity score, insurance status, operative approach, hospital bed size, hospital 
region, teaching status, transplant center status  




Table 4. Unadjusted outcomes following laparoscopic vs open appendectomy in kidney transplant 
recipients (KTR) and non-KTR.  
Outcome  KTR  
(n = 1336)  
Non-KTR  
(n = 2,640,247)  
p value  
Any Complication (%)  17.0  11.6  0.003  
   Laparoscopic  10.6  8.7  0.5  
   Open  22.4  14.8  0.009  
LOS, median days (IQR)  3 (2-6)  2 (1-4)  <0.001  
   Laparoscopic  3 (1-4)  2 (1-3)  <0.001  
   Open  4 (2-7)  3 (2-5)  <0.001  
Cost, median $ (IQR)  9,175   
(6,715-13,915)  
6,802  
(5,076- 9,358)  
<0.001  















Table 5. Unadjusted outcomes following laparoscopic vs open appendectomy in kidney transplant 
recipients ONLY.  
Outcome  Laparoscopic  
(n = 599)  
Open  
(n = 737)  
P value  
Performed at transplant center (%)  40.7  59.3  0.003  
Any complications (%)  10.6  22.4  0.009  
System specific complications^ (%)        
   Wound  0  4.6  0.016  
   Infection  4.1  5.9  0.5  
   Pulmonary  2.6  5.7  0.2  
   Cardiovascular  0  0  1.0  
   Genitourinary  0.8  1.3  0.7  
   Gastrointestinal  3.2  9.9  0.03  
   Intraoperative  0.8  2.0  0.4  
LOS, median days (IQR)  3 (1- 4)  4 (2-7)  <0.001  
Cost, median $ (IQR)  8,676   
(6575 – 11524)  




^see Appendix E for breakdown of complications by system    
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Table 6. Adjusted outcomes of kidney transplant recipients vs. non-transplant patients by center 
type.  
Outcome  Transplant center  Non-transplant center  p-value for 
interaction  
Any complications, OR   0.95 (0.54-1.67)  1.23 (0.75-2.0)  0.5  
LOS, ratio   1.36 (1.22-1.55)  0.96 (0.84-1.08)  <0.001  
Cost, ratio  1.29 (1.19-1.41)  1.01 (0.93-1.10)  0.004  
Laparoscopic approach, 
OR  
0.55 (0.36-0.85)  0.79 (0.51-1.21)  0.2  
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Background: Kidney transplant recipients (KTR) are at increased risk of requiring cholecystectomy. 
Given the physiologic impacts of years of renal replacement and lifelong immunosuppression, 
cholecystectomy may have higher risk in this unique population.  
Methods: Using the National Inpatient Sample, we compared 7,318 KTR and 5,341,427 non-KTR 
following cholecystectomy from 2000-2011, and investigated outcomes of mortality, morbidity, 
length of stay (LOS) and cost, adjusting for patient and hospital level factors.  
Results: For KTR compared to non-KTR, mortality (2.7% vs 1.2%, p<0.001) and morbidity (18.8% 
vs 13.9%, p<0.001; aOR 1.30 95%CI 1.12-1.51) were higher. LOS and costs were also greater (LOS 
ratio 1.23 95%CI 1.17-1.28; cost ratio 1.13 95%CI 1.08-1.17). When comparing outcomes at 
transplant and non-transplant centers, there were no differences.  
Conclusions: KTR have higher mortality and morbidity, longer LOS, and greater peri-operative cost 
following cholecystectomy. It is safe and cost effective for surgeons to choose to perform 
cholecystectomy at non-transplant centers. Physicians should consider the elevated risks when 





Cholecystectomy is one of the most common general surgery procedures performed in the United 
States, with more than 400,000 cases performed every year.9,10 One unique patient population at 
increased risk for need of cholecystectomy are kidney transplant recipients (KTR). KTR are at higher 
risk of developing gallstones and biliary disease than  the general population due to their history of 
renal failure and immunosuppressive medications such as calcineurin inhibitors.14,15 This risk, 
combined with improved post-transplant survival, translates to a higher incidence of cholecystectomy 
in the kidney transplant population.9,14 While post-cholecystectomy morbidity and mortality are low 
and the average hospital length of stay (LOS) is two days in the general population, it is unclear if the 
risks are elevated for KTR.11–13 An improved understanding of morbidity, LOS, and associated cost 
in this population is important for peri-operative planning and risk stratification. 
  
Previous single-center studies have reported that post-operative outcomes for solid organ transplant 
recipients following general surgical procedures are worse than the non-transplant recipients, with a 
recent review citing up to 32.7% morbidity and 17.5% mortality for emergency abdominal surgery, in 
comparison to 9% morbidity in non-transplant recipients.6,9 For cholecystectomy specifically, a 
national study of solid organ transplants, including heart, lung, and liver recipients, found a 
complication rate of 13.6% following cholecystectomy, compared to 4.9% for non-transplant 
recipients .9,11 Additionally, these heterogeneous solid-organ transplant recipients had a LOS of 4-8 
days, compared to a median 1 day reported for non-transplant recipients.11,22 Specifically regarding 
kidney transplant recipients, the largest case-series of cholecystectomies to date reported outcomes of 
17 procedures performed in a cohort of 1,608 KTR at a single transplant center, with a mortality rate 
of 5.9%.14 Given concerns of increased operative risks, many transplant providers feel that morbidity, 
LOS and cost might be mitigated if transplant recipients receive their surgical care at transplant 




To explore post-cholecystectomy outcomes in a more generalizable fashion, we used the National 
Inpatient Sample (NIS) to investigate the differences in mortality, morbidity, LOS and cost between 
KTR and non-KTR undergoing cholecystectomy in a large population of patients undergoing 
cholecystectomy in the United States. We also investigated post-operative outcomes based on the 




Patients were drawn from the National Inpatient Sample (NIS). Available through the Healthcare 
Cost and Utilization Project, the NIS contains data from approximately 7 million hospital stays 
yearly, and is made up of a stratified sample of 20% of the non-federal hospitals in the United States. 
The stratified sample is self-weighted to allow for population based estimates.57  Information 
provided in the NIS includes patient level hospital discharge data such as patient demographics, as 
well as diagnostic and procedural ICD-9 codes for the index hospital admission. All study methods 
were approved by the Johns Hopkins Hospital Institutional Review Board.  
 
Study population 
We studied 7,318 adult KTR and 5,341,427 non-KTR undergoing cholecystectomy from January 1, 
2000 - December 31, 2011. We included all patients who had International Classification of Disease, 
Ninth Revision (ICD-9) procedure codes for laparoscopic or open cholecystectomy KTR were 
distinguished from non-KTR by the presence of ICD-9 diagnosis codes consistent with prior KT. 
We excluded patients with ICD-9 codes indicating a history of other solid or non-solid organ 




Patient and Hospital Level Characteristics 
In addition to examining basic demographic characteristics and surgical approach (laparoscopic vs. 
open), the Charlson Comorbidity Index score was calculated for each patient.58,59  Hospital 
characteristics examined included standard NIS categories of location (rural or urban), size (small, 
medium, large), teaching status, and region (Northeast, Midwest, South, or West). We categorized 
hospitals as transplant centers or non-transplant centers. We defined a transplant center as a hospital 
where at least one kidney transplant was performed during the study period.  
 
Clinical Outcomes 
We defined peri-operative mortality as death during the primary surgical hospital admission. Peri-
operative morbidities, defined as intraoperative or postoperative complications during the index 
hospital admission, were identified by ICD-9 code and categorized into system-based groups as 
established in previous studies (Appendix E).26 
 
Mortality and complication rates were modeled using hierarchical logistic regression. Length of stay 
was examined using hierarchical negative binomial regression. Mixed linear regression was used to 
examine log-transformed costs, which were determined using the NIS cost-to-charge ratio files.  
 
All models included random intercepts for each hospital and were adjusted for patient characteristics 
(sex, age, African American race, Charlson Comorbidity Index, primary insurance status), hospital 
factors (location, size, region, teaching status, and transplant center status), and surgical approach 




Effect Modification by Transplant Center 
We investigated whether the association of KTR status with mortality, morbidity, LOS and cost 
varied by treatment at transplant centers vs. non-transplant centers. To evaluate the effect of 
transplant center type on the relationship of KTR and the outcomes above, we created an interaction 
term for KTR status with transplant center status in the regression models described above.  
 
Statistical Analysis  
We used χ2 tests to evaluate categorical variables and Student’s t test for continuous variables to 
compare KTR with non-KTR. For all analyses, a two-tailed p-value of < 0.05 was considered 
statistically significant. Confidence intervals are reported as per the method of Louis and Zeger.36 




A total of 7,318 KTR and 5,341,427 non-KTR underwent cholecystectomy during the study period. 
KTR were a similar age (52.9 vs 53.9 years, p=0.051), more likely to be male (55.3 vs 34.3%, 
p<0.001), African American (13.8 vs 9.3%, p <0.001), have public insurance (66.8% vs 46.3%, p 
<0.001) and had a higher Charlson Comorbidity Index scores (36.4% vs 16.9% with score ≥2) 
compared to non-KTR. KTR were less likely to have a laparoscopic cholecystectomy (68.2% vs 
77.7%, p<0.001, Table 1).   
 
Mortality and Morbidity 
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Mortality was higher following cholecystectomy during the index admission for KTR compared to 
non-KTR (2.7% vs 1.2%, p <0.001, Table 2). After adjusting for patient and hospital characteristics, 
the odds of mortality following cholecystectomy in KTR was 2.39-fold higher than non-KTR (aOR 
1.662.393.44). KTR were more likely than non-KTR to have postoperative complications during their 
surgical   hospitalization (18.8% vs 13.9%, p<0.001). KTR had more wound complications (2.0% vs 
0.8%, p <0.001), infectious complications (4.4% vs 2.1%, p<0.001), genitourinary complications 
(1.4% vs 0.8%, p=0.01) and intraoperative complications (3.7% vs 2.4%, p=0.001) than non-KTR. 
After adjustment, the odds of any morbidity were 1.3-fold higher in KTR than non-KTR (aOR 
1.121.301.51). KTR had 1.9-fold higher odds of wound complications (aOR 1.271.902.84) and infectious 
complications (aOR 1.441.892.48), as well as significantly higher odds of intraoperative (aOR 1.031.391.86) 
complications as well when compared to non-KTR (Table 2). 
 
Length of Stay and Cost 
Median LOS was longer in KTR compared to non-KTR (5 days vs 3 days, p <0.001, Table 2).  After 
adjusting for patient and hospital level characteristics including operative approach, LOS was 1.23-
fold longer for KTR (ratio 1.171.231.28). The median cost for cholecystectomy was $12,077 for KTR 
and $9,002 for non-KTR (p <0.001). Following adjustment, cost was 1.13-fold higher for KTR than 
non-KTR (ratio 1.081.131.17, Table 2).   
 
Transplant Center 
KTR were more likely to be treated at kidney transplant centers than non-KTR (54.6% vs 16.8%, p 
>0.001, Table 1). There was no difference in mortality for KTR vs non-KTR treated at transplant 
centers compared to those treated at non-transplant centers (aOR: 1.482.454.04 vs 1.362.313.93; interaction 
p=0.9, Table 3). There was no difference in odds of overall complications (aOR: 1.001.241.52 vs 
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1.111.371.69, interaction p=0.5), LOS (ratio: 1.181.251.32 vs 1.141.211.28, interaction p=0.4), or cost (ratio: 
1.071.131.18 vs ratio1.091.151.21, interaction p=0.7), when comparing treatment at transplant centers and 
non-transplant centers for KTR vs non-KTR (Table 3). 
 
DISCUSSION 
As the largest national study of kidney transplant recipients undergoing cholecystectomy, we found 
that KTR had 2.4-fold higher mortality and 30% higher overall morbidity when compared to non-
KTR. KTR were more susceptible to wound (aOR 1.90), infectious (aOR 1.89), and intraoperative 
complications (aOR 1.39) than non-KTR. KTR had 23% longer LOS and 13% higher cost than non-
KTR (p<0.001). These associations did not vary between transplant centers and non-transplant 
centers.   
 
We found 2.7% mortality in KTR, with 2.4-fold higher odds after adjusting for multiple patient and 
hospital characteristics, concordant with previous single-institution studies of 0-5.9% mortality in 
KTR.  Our findings from a larger, more generalizable cohort, support that cholecystectomy is 
inherently higher risk for KTR than non-KTR, independent of other patient, hospital, and procedure 
specific variables.14,16 Further, we found the rate of overall complications to be significantly higher in 
KTR. These findings are consistent with reported morbidity in 12.5% KTRs after cholecystectomy.67 
Specifically, we found that KTR suffered more wound, infectious, and intraoperative complications 
than non-KTR. Although the underlying cause for this increase in complications is multifactorial, it is 
certainly influenced by immunosuppression of KT recipients. The impact of immunosuppression on 
wound healing and infection is well documented, particularly in the immediate post-transplant 
setting.60,63,65,66 Even with improved immunosuppressant regimens, higher rates of wound healing 
issues and infectious complications have been documented in KTR.62 Additionally, the global tissue 
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damage caused by years of renal failure and/or dialysis might increase intraoperative complications as 
well.68,69  
 
We found the median LOS for KTR to be significantly longer than non-KTR (5 vs 3 days). We 
report a shorter median LOS than previous studies of solid organ transplant recipients undergoing 
cholecystectomy (9 days)9, but similar LOS to other reports for the general population (1-3 days).11  
Additionally, we report significantly higher cost for KTR compared to non-KTR. A recent study 
reported median cost of cholecystectomy in the general population ranging from $8,552 to $13,526 
for average length hospital stays, which is similar to our finding of $9,002 for non-transplant 
recipients.18 However, median cost for KTR was 13%% higher following adjustment. Although this 
difference is significant, the nature of our study data precluded a more granular examination of costs.  
 
Despite the sentiments expressed in multiple opinion pieces including book chapters and editorials, 
we did not find better outcomes for transplant recipients at transplant centers.24,30 While there was a 
significantly higher percentage of cholecystectomies performed at transplant centers in the KTR 
population (54.6%) compared to the non-KTR group (16.8%), the mortality, morbidity, LOS and 
cost were similar for KTR regardless of location of care. This suggests that cholecystectomies are 
safe and cost effective at non-transplant centers when surgeons feel comfortable treating KTR. 
 
Although laparoscopic cholecystectomy has evolved to become the surgical approach of choice for 
gallbladder surgery and a history of kidney transplantation is not considered a contraindication to 
laparoscopic cholecystectomy, we found a nearly 10% difference in the application of laparoscopic 
approach for KTR.7,16 This is consistent with a recent review that demonstrated laparoscopic 
57 
 
approach in 72% of cholecystectomy cases in transplant recipients, compared to 89.5% laparoscopic 
approach in the general population.9,11   
 
This study has some limitations which warrant further discussion. An important limitation is the lack 
of clinical granularity of NIS data. While the admitting diagnosis is routinely recorded and helpful in 
determining the indication for surgery, it is often vague. Therefore, we were unable to control for 
cholecystectomy indication. Without detailed information on the specific costs and events occurring 
during a hospital stay, we are also unable to determine the underlying reasons for cost and length of 
stay differences between KTR and non-KTR. For example, we were unable to determine whether 
those KTR presenting to non-transplant centers that were sicker were transferred to transplant 
centers for care. An additional limitation inherent in the design of the NIS is the lack of linkage of 
patients across multiple hospitalizations, thereby limiting ability to comment on later graft or patient 
outcomes. The magnitude of the NIS, however, offers insight into national outcomes of 
cholecystectomy in KTR and avoids the bias and limited power associated with single-center studies.  
 
In conclusion, we report that kidney transplant recipients have higher mortality, greater morbidity, 
longer LOS and higher cost when compared to non-transplant recipients undergoing 
cholecystectomy, regardless of location of care. Cholecystectomies are as safe and cost effective at 
non-transplant centers as they are at transplant centers if surgeons feel comfortable treating KTR. 
Our findings suggest that surgeons should consider these elevated risks when planning for surgery in 




Table 1. Characteristics of the study population, hospital and procedure details for kidney transplant 





























Age, mean (SD) 52.9 (13.5) 53.9 (19.1) 0.051 
Male, % 55.3 34.3 <0.001 
African American, % 13.8 9.3 <0.001 
Charlson Comorbidity Index, %   <0.001 
   0 35.5 61.7  
   1 28.1 21.4  
   ≥2 36.4 16.9  
Insurance Status, %   <0.001 
   Public 66.8 46.3  
   Private 30.0 42.5  
   Other 2.2 11.2  
Laparoscopic, % 68.2 77.7 <0.001 
Performed at transplant center, % 54.6 16.8 <0.001 
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Table 2. Unadjusted and adjusted* outcomes following cholecystectomy in kidney transplant 
recipients (KTR) vs non-KTR. 
 
 
*adjusted for age, race, gender, Charlson comorbidity score, insurance status, hospital bed size, hospital region, teaching 
status, surgical approach  
^see Appendix E for breakdown of complications by system 
  
 Unadjusted Adjusted* 
Outcome KTR 
(n = 7318) 
Non-KTR 
(n = 5,341,427) 
p value KTR vs  
Non-KTR 
95% CI 
Mortality, % 2.7 1.2 <0.001 2.39 1.66-3.44 
Any Complication, % 18.8 13.9 <0.001 1.30 1.12-1.51 
System specific 
complications,^ % 
     
   Wound 2.0 0.8 <0.001 1.90 1.27 -2.84 
   Infection 4.4 2.1 <0.001 1.89 1.44-2.48 
   Pulmonary 3.3 3.3 0.9 0.99 0.72-1.35 
   Cardiovascular 1.2 1.2 0.9 0.89 0.51-1.54 
   Genitourinary 1.4 0.8 0.01 1.48 0.91-2.41 
   Gastrointestinal 5.9 5.8 0.8 0.88 0.69-1.12 
   Intraoperative 3.7 2.4 0.001 1.39 1.03-1.86 
LOS, median days 
(IQR) 
5 (3-9) 3 (2-6) <0.001 1.23 1.17-1.28 




<0.001 1.13 1.08-1.17 
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Table 3. Adjusted outcomes of kidney transplant recipients vs. non-transplant patients by center type 
following cholecystectomy. * 
Outcome Transplant center Non-transplant center p-value for 
interaction 
Mortality, OR 2.45 (1.48 - 4.04) 2.31 (1.36 - 3.93) 0.9 
Any complications, OR  1.24 (1.00 - 1.52) 1.37 (1.11 - 1.69) 0.5 
LOS, ratio  1.25 (1.18-1.32) 1.21 (1.14 - 1.28) 0.4 
Cost, ratio 1.13 (1.07-1.18) 1.15 (1.09-1.21) 0.7 
  
*adjusted for age, race, gender, Charlson comorbidity score, insurance status, hospital bed size, hospital region, teaching 
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Purpose: Kidney transplant recipients (KTR) are at increased risk of requiring colorectal resection 
compared to the general population. Given the need for lifelong immunosuppression and the 
physiologic impact of years of renal replacement, we hypothesized that colorectal resection may be 
riskier for this unique population.  
Methods: We investigated the differences in mortality, morbidity, length of stay (LOS), and cost 
between 2,410 KTR and 1,433,437 non-KTR undergoing colorectal resection at both transplant and 
non-transplant centers using the National Inpatient Sample between 2000-2013, adjusting for patient 
and hospital level factors.  
Results: In hospital mortality was higher for KTR in comparison to non-KTR (11.1 vs 4.3%, 
p<0.001; adjusted odds ratio [aOR] 2.683.594.81) as were overall complications (38.5 vs 31.5%, p 
=0.001; aOR 1.081.301.56). LOS was significantly longer (10 vs 7 days, p <0.001; ratio 1.421.531.65) and 
cost was significantly greater ($23,056 vs $14,139, p<0.001; ratio 1.421.541.63) for KTR compared to 
non-KTR. While LOS was longer for KTR undergoing resection at transplant centers compared to 
non-transplant centers (aOR 1.68 vs 1.53, p=0.03), there were no statistically significant differences 
in mortality, overall morbidity, or cost by center type.  
Conclusions: KTR have higher mortality, higher incidence of overall complications, longer LOS, 
and higher cost than non-KTR following colorectal resection, regardless of center type. Physicians 
should consider these elevated risks when planning for surgery in the KTR population and counsel 
patients accordingly. 
 






More than 300,000 colectomies are performed in the annually in the United States for a variety of 
pathologies, including diverticulitis and cancer.17,18 Because transplant recipients are at increased risk 
of these diseases, they are more likely to require colorectal resections compared to the general 
population. For example, transplant recipients have 2.6x higher incidence of colorectal cancer than 
non-transplant recipients19, with a 5-year cumulative incidence rate of 0.5%.20 Kidney transplant 
recipients (KTR) also have a higher incidence of acute diverticulitis than the general population 
(0.94% vs 0.02%).21 Furthermore, as post-transplant survival improves and the KTR population ages, 
the number of KTR requiring colorectal resection will increase proportionally.55,56 An improved 
understanding of mortality, morbidity, length of stay, and associated cost of colorectal resection in 
this population is important for peri-operative planning and risk stratification. 
 
A systematic review of single-institution studies of immunosuppressed patients demonstrated a 23% 
mortality rate for colorectal resection for diverticulitis21, while another found 17.5% mortality 
following resection for colonic perforation9, both significantly higher than anticipated in the general 
population.17  As with other types of general surgery in KTR, single-institution case series have 
demonstrated a prolonged length of stay (LOS) following colorectal resection, with one study 
reporting a median LOS of 22.2 days compared to a national average of 9.3 days for open 
colectomy.9,26,70 Given concerns of increased operative risk, it has been suggested that any increased 
morbidity, LOS or  cost might be reduced if transplant recipients receive their surgical care at 
transplant centers.24,25,30 
 
We used the National Inpatient Sample (NIS), a large, nationally representative database, to 
investigate the differences in mortality, morbidity, length of stay and cost between KTR and non-
KTR undergoing colorectal resection in the United States. We also investigated post-resection 
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outcomes based on the location of surgical care at transplant centers compared to non-transplant 
centers.  
 
MATERIALS AND METHODS 
Data Source 
Patients were drawn from the NIS. Available through the Health Care Cost and Utilization Project, 
the NIS contains data from approximately 7 million hospital stays yearly and is made up of a 
stratified sample of 20% of the non-federal hospitals in the United States. The stratified sample is 
self-weighted to allow for population based estimates.57  Information provided in the NIS includes 
patient level hospital discharge data such as patient demographics, as well as diagnostic and 
procedural ICD-9 codes for the index hospital admission. All study methods were approved by the 
Johns Hopkins Hospital Institutional Review Board.  
 
Study Population 
We studied 2,410 KTR and 1,433,437 non-KTR undergoing colorectal resections from January 1, 
2000 - December 31, 2013. We limited the study to patients who had an International Classification 
of Disease, Ninth Revision (ICD-9) procedure code for laparoscopic or open colorectal resection 
and included both elective and urgent/emergent indications. KTR were distinguished from non-KTR 
by the presence of ICD-9 diagnosis codes consistent with prior kidney transplantation. We excluded 
patients with ICD-9 codes indicating a history of other solid or non-solid organ transplants 
(Appendix A) and patients who underwent both kidney transplantation and colorectal resection 
during the same hospital admission. 
 
Patient, Hospital, and Procedure Characteristics 
Basic demographic information was examined and the Charlson Comorbidity Index Score was 
calculated for each patient.1,2 Hospital and procedure characteristics included standard NIS categories 
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of location (rural or urban), size (small, medium, large), teaching status, region (Northeast, Midwest, 
South, or West), surgical approach (laparoscopic vs open), case status (elective vs urgent/emergent), 
and calendar year. In addition, we categorized hospitals as transplant centers (a hospital where at least 
one kidney transplant was performed during the study period) or non-transplant centers.  
 
Clinical Outcomes 
We defined mortality as death during the primary surgical hospital admission. Morbidity, defined as 
intraoperative or postoperative complications during the primary surgical hospital admission, were 
identified by ICD-9 code and categorized into system-based groups as established in previous studies 
(Appendix B).3 Incidence of mortality and morbidity were modeled using hierarchical logistic 
regression. Length of stay was examined using hierarchical negative binomial regression. Mixed linear 
regression was used to examine log-transformed costs, which were determined using the NIS cost-to-
charge ratio files.  
 
All models included random intercepts for each hospital and were adjusted for patient (sex, age, 
African American race, Charlson Comorbidity Index, primary insurance status) and hospital factors 
(location, size, region, teaching status, and transplant center status). Secular trends were evaluated by 
adjusting all models for calendar year. Variables for case status and surgical approach were not 
associated with outcomes in univariable or multivariable models; for model parity they were not 
included in reported models.   
 
Effect Modification by Transplant Center 
We investigated whether the association of KTR status with mortality, morbidity, LOS and cost 
varied by treatment at transplant centers vs. non-transplant centers. To evaluate the effect of 
transplant center type on the relationship of KTR and the outcomes above, we created an interaction 




Statistical Analysis  
We used χ2 tests to evaluate categorical variables and Student’s t test for continuous variables to draw 
between-group comparisons. For all analyses, a two-tailed p-value of < 0.05 was considered 
statistically significant. Confidence intervals are reported as per the method of Louis and Zeger.36 




In total, 2,410 KTR and 1,433,437 non-KTR underwent colorectal resection during the study period. 
KTR were younger (58.2 vs 65.1 years, p<0.001), more likely to be male (58.7% vs 46.2%, p<0.001), 
African American (20.2% vs 10.2%, p<0.001), have public insurance (68.4% vs 59.1%, p<0.001) and 
have higher Charlson Comorbidity Index scores (43.2% vs 35.7% with score ≥3). KTR were less 
likely to have a laparoscopic colorectal resection (20.4% vs 30.5%, p=0.002) and less likely to 
undergo an elective procedure (47.3% vs 61%, p >0.001) (Table 1).   
 
Mortality and Morbidity 
Mortality was higher following colorectal resection for KTR compared to non-KTR (11.1% vs 4.3%, 
p <0.001). After adjusting for patient and hospital characteristics, the odds of mortality following 
colorectal procedures in KTR was 3.59-fold higher than non-KTR (aOR 2.683.594.81). KTR were more 
likely than non-KTR to have postoperative complications during their surgical hospitalization (38.5% 
vs 31.5%, p = 0.001). Specifically, KTR had more wound complications (6.2% vs 2.4%, p <0.001), 
infectious complications (7.7% vs 4.2%, p<0.001), cardiovascular complications (5.2 vs 2.7%, 
p<0.001), pulmonary complications (8.0% vs 5.3%, p=0.008) and intraoperative complications (6.5% 
vs 3.9%, p=0.003) than non-transplant recipients (Table 2). After adjustment, the odds of overall 
morbidity were 1.30-fold higher in KTR than non-KTR (aOR 1.081.301.56). Specifically, KTR had 
67 
 
higher odds of cardiovascular (aOR 1.452.193.31), wound (aOR 1.351.972.87), infectious (aOR 1.081.522.13), 
pulmonary (aOR 1.211.702.39), and intraoperative (aOR 1.151.662.38) complications when compared to 
non-KTR (Table 3).  
 
Length of Stay and Cost 
Median length of stay (LOS) was longer in KTR compared to non-KTR (10 days vs 7 days, 
p<0.001). Following adjustment, KTR had a 53% longer LOS than non-KTR (ratio 1.431.531.65).  Cost 
of care was higher for KTR than non-KTR, with a median difference of $9,000 dollars ($23,056 vs 
$14,139, p <0.001). Following adjustment, cost was 54% higher in KTR than non-KTR (ratio 
1.421.531.63) (Tables 2 & 3). 
 
Transplant Center 
KTR were more likely to be treated at kidney transplant centers than non-KTR (29.9% vs 8.9%, p 
>0.001) (Table 1). The association of KTR status and mortality did not differ by center type 
(interaction p=0.6). The association of KTR status and overall complications and most system 
specific complications did not differ by center type (Table 4). Among colorectal resection patients at 
transplant centers, there was no association between KTR status and infection. However, for 
colorectal resection at non-transplant centers, KTR had a 2-fold increased risk of infection compared 
to non-KTR (aOR 1.361.992.91, interaction p= 0.03). Additionally, among KTR treated at transplant 
centers, LOS was longer than at non-transplant centers (ratio 1.68 vs 1.53, interaction p= 0.03). The 
association of KTR status and cost did not differ by center type (Table 4).  
 
DISCUSSION 
In this national, 14-year study of 2,410 kidney transplant recipients undergoing colorectal resection, 
we found that KTR had a 3.6-fold increase in mortality and 1.3-fold increase in overall morbidity 
when compared to non-KTR. KTR were more susceptible to wound (6.2 vs 2.4%), infectious (7.7 vs 
68 
 
4.2%), cardiovascular (5.2 vs 2.7%), pulmonary (8.0 vs 5.3%) and intraoperative (6.5 vs 3.9%) 
complications than non-KTR. Cost was 1.5-fold higher for KTR compared to non-KTR. KTR also 
had a 1.5-fold longer LOS than non-KTR, with an additional 15% increase in LOS when KTR are 
treated at transplant centers.  
 
Our findings of significantly higher mortality in KTR undergoing colorectal resection are consistent 
with and expand on single-institution studies of solid organ transplant recipients which document 7 
to 10% mortality rates from colorectal disease complications.71–73 A recent national study of 
emergency colorectal surgery reported a 9.3% mortality rate,17 appropriately higher than the rate we 
report for the non-transplant population (4%), given that our sample contains both elective and 
urgent/emergent surgical resections. However, considering nearly half of the transplant recipients in 
our study population had elective resections, the 3.6-fold increase in mortality that we report after 
adjustment is striking.  
 
Furthermore, we found the rate of overall complications to be significantly higher in KTR. 
Specifically, we found that KTR suffered more wound, infectious, cardiovascular, pulmonary, and 
intraoperative complications than non-KTR. These findings are consistent with a recent systematic 
review of gastrointestinal complications in solid organ transplant recipients that reported a 33% 
incidence of complications following resection for diverticular disease, and several single institution 
case series reporting between 60-100% complication rate for colorectal resections for diverticulitis or 
lower gastrointestinal perforations.9,55,71  
 
Although the underlying cause for our findings of increased mortality and complications is 
multifactorial, it is likely heavily influenced by immunosuppression. The impact of 
immunosuppression on wound healing and infection is well documented, particularly in the 
immediate post-transplant setting.60,63 Even with improved immunosuppressant regimens, higher 
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rates of wound healing issues and infectious complications have been documented in KTR.62,74 In 
addition, we have demonstrated that cardiovascular, pulmonary and intraoperative complications are 
more frequent in KTR. The global tissue damage caused by years of renal failure and/or dialysis is 
potentially responsible for an increase in complications associated with these organ systems and 
subsequent mortality.69  
 
We found the median length of stay for kidney transplant recipients to be significantly longer than 
non-transplant recipients (10 vs 7 days), particularly when treated at a transplant center (11 vs 7 days). 
The median LOS we report for the general population is similar to other reports that document LOS 
of 6-9 days following open colorectal resection, as only 20% of patients in our study underwent 
laparoscopic approach.18,26 Our findings are consistent with longer LOS documented in other 
smaller, single institutions studies of transplant recipients undergoing general surgical 
procedures.70,75,76 Additionally, we reported significantly higher cost for kidney transplant recipients 
compared to non-transplant recipients. A recent national study of colectomy reported median costs 
ranging from $12,071 - 14,141 depending on surgical approach for the general population, which is 
similar to our finding of median cost of $14,139 for non-transplant recipients.18 However, median 
cost for kidney transplant recipients was 54% higher following adjustment. While this difference is 
significant, the nature of our study data precluded a more granular examination of costs.  
 
Despite the sentiments expressed in multiple opinion pieces including book chapters and editorials, 
we did not find better outcomes for transplant recipients at transplant centers.24,30,32 In fact, we found 
that KTR had a 15% longer LOS when treated at transplant centers. Given the constellation of 
similar mortality, morbidity and cost in the setting of longer LOS at transplant centers, the longer 
LOS does not appear to be attributable to a difference in illness severity at transplant centers 
compared to non-transplant centers. This is potentially suggestive of more conservative discharge 




This study has some limitations that warrant further discussion. An important limitation was the lack 
of clinical granularity of NIS data. While the admitting diagnosis was routinely recorded and helpful 
in determining the indication for surgery, it was often vague, hindering our ability to adjust for 
colorectal resection indication. Without detailed information on the specific costs and events 
occurring during a hospital stay, we were also unable to determine the underlying reasons for cost 
and length of stay differences between KTR and non-KTR, and between transplant centers and non-
transplant centers. We were unable to determine whether, for example, those KTR presenting to 
non-transplant centers who were sicker were transferred to transplant centers for care. An additional 
limitation inherent in the design of the NIS was the lack of longitudinal follow-up across multiple 
hospitalizations, and the lack of linkage to transplant registries, thereby limiting our ability to study 
later graft or patient outcomes. The magnitude of the NIS, however, offers an understanding of the 
national outcomes of colorectal resections in KTR and avoids the bias and limited power associated 
with single-center studies. It also allows us to perform multivariable analyses, investigate interactions, 
and study outcomes at transplant vs non-transplant centers.  
 
CONCLUSION 
In this large national study, kidney transplant recipients had higher mortality, greater morbidity, and 
higher cost when compared to non-transplant recipients following colorectal resection, regardless of 
center type. Current patient selection practice by surgeons suggests that if surgeons feel comfortable 
operating, colorectal resection at non-transplant centers are as safe and as cost-effective as transplant 
centers, with even shorter length of stay. Our findings suggest that surgeons should consider the 
elevated risks when planning for surgery in the KTR population and counsel patients accordingly, but 




Table 1. Characteristics and hospital and procedure details for kidney transplant recipients (KTR) and 































Age, mean (SD) 58.2 (11.9) 65.1 (15.5) <0.001 
Female, % 41.3 53.8 <0.001 
African American, % 20.2 10.2 <0.001 
Charlson Comorbidity Index, %   <0.001 
   0 22.8 31.1  
   1 10.2 11.8  
   2 23.8 21.4  
   ≥3 43.2 35.7  
Insurance Status, %   <0.001 
   Public 68.4 59.1  
   Private 29.7 36.1  
   Other 1.8 4.8  
Hospital bed size, %   <0.001 
   Small 3.9 11.7  
   Medium 20.6 24.9  
   Large 75.6 63.4  
 Hospital location/teaching status, %   <0.001 
   Rural 2.9 10.0  
   Urban non-teaching 24.8 44.2  
   Urban teaching 72.3 45.8  
Hospital region, %   0.5 
   Northeast 23.0 23.6  
   Midwest 19.3 17.5  
   South 37.7 40.4  
   West 20.0 18.5  
Laparoscopic, % 20.4 30.5 <0.001 
Performed at transplant center, % 29.9 8.9 <0.001 
Elective case, % 47.3 61.0 <0.001 
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(n = 2410) 
Non-KTR 
(n = 1,443,437) 
P value 
Mortality, % 11.1 4.3 <0.001 
Any Complication, % 38.5 31.5 0.001 
System specific complications,^ %    
   Wound 6.2 2.4 <0.001 
   Infection 7.7 4.2 <0.001 
   Pulmonary 8.0 5.3 0.008 
   Cardiovascular 5.2 2.7 <0.001 
   Thromboembolic 0.4 0.3 0.7 
   Genitourinary 2.2 1.3 0.08 
   Gastrointestinal 18.4 19.3 0.6 
   Intraoperative 6.5 3.9 0.003 
LOS, median days (IQR) 10 (6-20) 7 (5-11) <0.001 
   At KT center 11 (7-24) 7 (5-12) <0.001 
   At non-KT center 9 (6-18) 7 (5-11) <0.001 
Cost, median $ (IQR) 23,056 (13,408-45,217) 14,139 (9,642-23,313) <0.001 
   At KT center, median $ (IQR) 21,360 (13,475-50,380) 15,615 (10,613 – 26,152) <0.001 
   At non-KT center, median $ (IQR) 23,899 (13,380-43,015) 13,964 (9,547 – 23,036) <0.001 
 





Table 3. Adjusted outcomes* following colorectal resection in kidney transplant recipients (KTR) vs 
non-KTR. 
 
Outcome KTR vs Non-
KTR 
95% CI 
In hospital mortality, OR 3.59 2.68-4.81 
Any complication, OR  1.30 1.08-1.56 
System specific complications^, OR   
   Wound 1.97 1.35-2.87 
   Infection 1.52 1.08-2.13 
   Pulmonary 1.70 1.21-2.39 
   Cardiovascular 2.19 1.45-3.31 
   Thromboembolic 1.22 0.30-4.95 
   Genitourinary 1.81 0.98-3.31 
   Gastrointestinal 0.91 0.72-1.15 
   Intraoperative 1.66 1.15-2.38 
LOS, ratio 1.53 1.42-1.65 
Cost, ratio 1.54 1.42-1.63 
 
^see Appendix E for breakdown of complications by system 
*adjusted for age, race, gender, Charlson comorbidity score, insurance status, hospital bed size, hospital region, teaching 





Table 4. Adjusted outcomes* following colorectal resection for kidney transplant recipients (KTR) vs. 
non-KTR by center type. 
 
Outcome Transplant center Non-transplant center p-value for 
interaction 
Mortality, OR 3.95 (2.39-6.51) 3.43 (2.39-4.91) 0.6 
Any complication, OR  1.44 (1.02-2.01) 1.24 (0.99-1.55) 0.7 
System specific complications^, OR    
   Wound 1.84 (1.01-3.37) 2.05 (1.27-3.33) 0.8 
   Infection 0.75 (0.38-1.63) 1.99 (1.36-2.91) 0.03 
   Pulmonary 1.02 (0.52-2.03) 2.12(1.43-3.14) 0.07 
   Cardiovascular 2.93 (1.56-5.51) 1.83(1.07-3.16) 0.3 
   Thromboembolic± 1.99 (0.49-8.07) - - 
   Genitourinary 2.43 (0.98-6.03) 1.49 (0.66-3.38) 0.4 
   Gastrointestinal 1.02 (0.67-1.57) 0.87 (0.65-1.15) 0.5 
   Intraoperative 1.09 (0.53-2.24) 1.99 (1.31-3.02) 0.2 
LOS, ratio  1.68 (1.50-1.87) 1.53 (1.43-1.65) 0.03 
Cost, ratio 1.50 (1.33-1.68) 1.54 (1.41-1.68) 0.8 
  
^see Appendix E for breakdown of complications by system 
*adjusted for age, race, gender, Charlson comorbidity score, insurance status, hospital bed size, hospital region, teaching 
status, transplant center, calendar year 
±no thromboembolic events occurred at non-transplant centers   
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Chapter 6. Conclusion 
 
From our nationally distributed survey, we found that the majority of surveyed acute care (AC) 
surgeons and transplant surgeons felt comfortable performing laparoscopic or open acute care 
surgery on transplant recipients. Transplant surgeons reported high comfort with these procedures 
despite performing fewer advanced cases in their routine practice than acute care surgeons and 
despite few regularly taking general surgery call. The vast majority of surgeons believed that 
transplant recipients receive better care at transplant centers and recommended treating transplant 
recipients at transplant centers whenever feasible. AC surgeons at transplant and non-transplant 
centers and transplant surgeons recommended that transplant recipients requiring acute care surgery 
who were less than 5-years post-transplant or had acute organ failure should be transferred to 
transplant teams or centers, respectively.   
In our analysis of outcomes following appendectomy among kidney transplant recipients (KTR), we 
found that KTR have similar rates of overall complications when compared to non-transplant 
recipients. Despite similar complication rates, appendectomy for KTR at transplant centers was 
associated with longer LOS and higher cost than at non-transplant centers. Our findings also suggest 
that appendectomy in KTR at non-transplant centers is safe and cost effective.   
Regarding cholecystectomy and colorectal resection, we report that kidney transplant recipients had 
higher mortality, greater morbidity, longer LOS, and higher cost when compared to non-transplant 
recipients. Despite worse outcomes among KTR following cholecystectomy, outcomes for these 
patients did not vary if they were treated at a transplant centers or non-transplant centers. Following 
colorectal resection, length of stay was, however, significantly longer for KTR at transplant centers 
compared to non-transplant centers; the remaining post-colorectal resection outcomes did not vary 
by center type. 
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In our national survey, we found that surgeons working at transplant centers believed the length of 
stay would be shorter at transplant centers, while AC surgeons at non-transplant centers believed it 
would be the same regardless of center type. Our retrospective analyses using the National Inpatient 
Sample directly contradict these surgeon beliefs. We found that LOS was longer following 
appendectomy and colectomy at transplant centers compared to non-transplant centers. 
Furthermore, the majority of surgeons surveyed believed that hospital cost would be the same for 
care regardless of transplant center type, however, cost following appendectomy was significantly 
higher at transplant centers. The disconnect between surgeon perceptions and nationally 
representative data could be undermining attempts to improve care for transplant recipients. For 
example, if surgeons believe transplant centers will provide superior care and incur similar LOS and 
cost for transplant recipients, they may be more inclined to transfer their transplant recipient to a 
transplant center, when in reality, the patient would have had a similar rate of complications at the 
non-transplant center and enjoy shorter LOS and lower cost.  
 Our findings suggest that surgeons should carefully counsel previous transplant recipients and 
vigilantly monitor for post-operative complications given their elevated risks of mortality and 
morbidity, longer LOS, and higher post-operative costs, particularly following cholecystectomy and 
colorectal resection. Our findings do not support the broad recommendation of transferring 
transplant recipients to transplant centers for acute care surgery, given largely similar rates of 
complications for transplant recipients between center types. Finally, our novel documentation of 
surgeon perceptions regarding acute care surgery in transplant recipients motivates future prospective 
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Appendix A. Complete survey instrument 
 
Performing General Surgical Procedures on Transplant Recipients:   
Surgeon Perspectives   
    
We would like to thank you for participating in this short survey, which should only take 3-5 minutes 
of your time. Our goals are to characterize the opinions and attitudes of surgeons regarding 
performing non-transplant surgical procedures on transplant recipients.    
    
Your completion of this questionnaire will serve as your consent to be in this research study. 
IRB00127443 Johns Hopkins University  
 
 
Please indicate your number of years in practice following completion of training (residency or 
fellowship if applicable): 
o <5  (1)  
o 5-10  (2)  
o 11-20  (3)  
o 21+  (4)  
o Still in training  (5)  
 
 
Please indicate your personal approximate case volume per year: 
o <100 cases  (1)  
o 101-200  (2)  
o 201-300  (3)  





Please select the type of hospital at which you primarily practice: 
o Community  (1)  
o Community with academic affiliation  (2)  
o Academic/Teaching  (3)  
o Other  (4) ________________________________________________ 
 
 
Please indicate the setting of your primary practice location: 
o Rural  (1)  
o Urban  (2)  
o Suburban  (3)  
 
 
Is your hospital a transplant center? 
o Yes  (1)  





Display This Question: 
If Is your hospital a transplant center? = No 
How close is the nearest transplant center to you? 
o <10 miles  (1)  
o 10-19 miles  (2)  
o 20-49 miles  (3)  
o 50-100 miles  (4)  
o >100 miles  (5)  
o I don't know  (6)  
 
End of Block: Demographics 
 
Start of Block: Your Practice 
Display This Question: 
If Is your hospital a transplant center? = Yes 
What is the scope of practice of transplant surgeons at your hospital? 
o Practice general surgery and perform transplants  (1)  
o Practice general surgery ON TRANSPLANT PATIENTS ONLY and perform transplants  
(2)  
o Do not practice general surgery, ONLY perform transplants  (3)  





Display This Question: 
If Is your hospital a transplant center? = Yes 
Do you perform transplant surgery? 
o Yes  (1)  
o No  (2)  
 
 
Display This Question: 
If Do you perform transplant surgery? = Yes 
Which transplant surgeries do you perform routinely? Select all that apply. 
▢  Kidney  (1)  
▢  Liver  (2)  
▢  Pancreas  (3)  
▢  Small bowel  (4)  
▢  Other:  (5)  
 
 
 Do you take acute care surgery, emergency general surgery, or trauma surgery call?  
o Yes  (1)  





Which of the following cases do you perform in your current practice (select all that apply)? 
▢  Appendectomy  (1)  
▢  Cholecystectomy  (2)  
▢  Hernia repair  (3)  
▢  Colectomy  (4)  
▢  Small bowel resection  (5)  
▢  Gastrectomy  (6)  




Do you perform laparoscopic procedures, specifically appendectomy or cholecystectomy? 
o Yes  (1)  
o No  (2)  
 
 
Display This Question: 
If Do you perform transplant surgery? = No 
Or Do you perform transplant surgery? , Yes Is Not Displayed 
Or Do you perform transplant surgery? != Yes 
Have you ever operated on a patient with a history of prior transplant? 
o Yes  (1)  





Display This Question: 
If Do you perform transplant surgery? = Yes 
In your practice following completion of training, do you perform non-transplant surgery on patients 
with a history of prior transplant? 
o Yes, often  (1)  
o Yes, occasionally  (2)  
o Yes, rarely  (3)  
o No  (4)  
 
End of Block: Your Practice 
 
Start of Block: Reasonable Standard of Care- Txp Center ACS Surgeon 
Display This Question: 
If Is your hospital a transplant center? = Yes 
And Do you perform transplant surgery? = No 
If you were consulted on a transplant recipient needing an ELECTIVE operation, would you refer 
them to the transplant surgery team? 
o Yes  (1)  
o No  (2)  
 
 
Display This Question: 
If Do you perform transplant surgery? = Yes 
If you were consulted on a transplant recipient needing an ELECTIVE general surgery operation, 
would you refer them to an acute care/general surgeon? 
o Yes, in all cases  (1)  
o Yes, but only for complex procedures  (2)  





Display This Question: 
If Is your hospital a transplant center? = No 
If you were consulted on a transplant recipient needing an ELECTIVE operation, would you rather 
refer them to a surgeon at a transplant center? 
o Yes  (1)  
o No  (2)  
 
 
Display This Question: 
If Is your hospital a transplant center? = Yes 
And Do you perform transplant surgery? = No 
If you were consulted on a transplant recipient needing an ELECTIVE operation, would you operate 
on the patient BUT ALSO contact a transplant surgeon for assistance? 
o Always  (1)  
o Most of the time  (2)  
o Sometimes  (3)  
o Rarely  (4)  
o Never  (5)  
 
 
Display This Question: 
If Is your hospital a transplant center? = Yes 
And Do you perform transplant surgery? = No 
If you were consulted on a transplant recipient needing an URGENT/EMERGENT operation, 
would you refer them to the transplant surgery team? 
o Yes  (1)  





Display This Question: 
If Is your hospital a transplant center? = No 
If you were consulted on a transplant recipient needing an URGENT/EMERGENT operation, 
would you rather transfer them to a transplant center if possible? 
o Yes  (1)  
o No  (2)  
 
 
Display This Question: 
If Do you perform transplant surgery? = No 
If you were consulted on a transplant recipient needing an URGENT/EMERGENT operation, 
would you operate on the patient BUT ALSO contact a transplant surgeon for assistance? 
o Always  (1)  
o Most of the time  (2)  
o Sometimes  (3)  
o Rarely  (4)  
o Never  (5)  
 
 
Display This Question: 
If Do you perform transplant surgery? = Yes 
If you were consulted on a transplant patient needing an URGENT/EMERGENT general surgery 
operation, would you refer them to an acute care/general surgeon? 
o Yes  (1)  
o No  (2)  
 
Skip To: Q19 If you were consulted on a transplant patient needing an URGENT/EMERGENT general surgery 




Display This Question: 
If Do you perform transplant surgery? = Yes 
If you would not typically refer a transplant recipient needing an URGENT/EMERGENT general 
surgery operation but would rather perform the operation yourself, would you contact an acute 
care/general surgeon for preoperative or intraoperative assistance? 
o Always  (1)  
o Most of the time  (2)  
o Sometimes  (3)  
o Rarely  (4)  
o Never  (5)  
 
 
Would you feel comfortable using laparoscopy on transplant recipients requiring acute care surgery 
procedures (appendectomy, cholecystectomy)? 
o Yes  (1)  
o No, but I do laparoscopy on non-transplant recipients  (2)  
o No, but I prefer not to use laparoscopic techniques on any patients  (3)  
o No, because I would not feel comfortable performing acute care surgery on transplant 





Display This Question: 
If Is your hospital a transplant center? = No 
Do you have the ability to contact a transplant center or transplant surgeon to ask for help or advice 
if needed? 
o Yes, easily  (1)  
o Yes, but it would be difficult  (2)  
o No  (3)  
 
 
Does your hospital or practice group have a policy regarding who is responsible for operating on 
transplant patients for non-transplant surgeries? 
o Yes  (1)  
o No  (2)  
o Unsure  (3)  
 
 
Display This Question: 
If Is your hospital a transplant center? = Yes 
At your primary hospital, who should perform urgent/emergent general surgery operations on 
transplant recipients? 
o Acute care surgeons  (1)  





Display This Question: 
If Is your hospital a transplant center? = Yes 
If patients have a history of transplant at a DIFFERENT hospital and comes to your transplant 
center with a need for acute care surgery, who usually performs procedures on these patients? 
o Acute care surgeons  (1)  
o Transplant surgeons  (2)  
o Either/It depends  (3)  
 
 
Do transplant recipients get better care following general surgery procedures if they are cared for at 
transplant centers? 
o Yes  (1)  
o No  (2)  
 
 
Should transplant recipients be transferred to transplant centers for urgent/emergent general surgery 
needs whenever possible? 
o Yes  (1)  
o No  (2)  
 
 
Display This Question: 
If Do you perform transplant surgery? = No 
If you performed an operation on a transplant recipient, would you send them for follow up with a 
transplant provider? 
o Yes  (1)  





The hospital cost ($) is higher for transplant recipients undergoing general surgery: 
o At transplant centers  (1)  
o At non-transplant centers  (2)  
o Cost is the same regardless of center type  (3)  
 
 
The length of stay is longer  for transplant recipients undergoing general surgery: 
o At transplant centers  (1)  
o At non-transplant centers  (2)  
o Length of stay is the same regardless of center type  (3)  
 
End of Block: Reasonable Standard of Care- Txp Center ACS Surgeon 
 
Start of Block: Concerns 
94 
 
What is/would be the most concerning about performing general surgery on previous transplant 
recipients? 
o Wound healing complications  (1)  
o Risk of renal failure  (2)  
o Increased risk of mortality  (3)  
o Management of postoperative medications  (4)  
o Intraoperative issues (anesthesia)  (5)  
o Anatomical differences  (6)  
o Higher risk of other complications  (7)  
o Other  (8) ________________________________________________ 
 
What is the most important cause of increased complications for transplant recipients following 
general surgery? 
o Steroid use  (1)  
o Other transplant medication use  (2)  
o History of organ failure causes irreparable damage to tissues  (3)  
o Transplanted organs less resilient to insult (acute renal failure, acute liver failure)  (4)  





Display This Question: 
If Do you perform transplant surgery? = No 
Do you feel that your hospital is equipped to care for postoperative complications (ICU 
support) for transplant patients undergoing general surgery? 
o Yes  (1)  
o No  (2)  
 
 
Display This Question: 
If Do you perform transplant surgery? = No 
And Is your hospital a transplant center? = Yes 
The #1 reason why I would PREOPERATIVELY transfer a transplant patient needing 




Display This Question: 
If Do you perform transplant surgery? = No 
And Is your hospital a transplant center? = No 
The #1 reason why I would PREOPERATIVELY transfer a transplant patient needing 
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Appendix B. International Classification of Diseases, 9th Revision codes for 
diagnosis, procedure, inclusion and exclusion criteria for appendectomy.  
  
Diagnosis  
   Appendicitis 540.0, 540.1, 540.9, 541, 542, 789.03  
Procedure  
   Appendectomy, laparoscopic 47.07  
   Appendectomy, open 47.0  
Inclusion  
   Kidney transplant recipient: V42.0  
Exclusion  
   Other (non-kidney) transplant recipients: V42.1, V42.2, V42.6, V42.7, V42.8, V42.81, V42.82, 
V42.83, V42.84, V42.89, V42.9   
  Complications from history of other (non-kidney) transplant: 996.80, 996.82, 996.83, 996.84, 




Appendix C. International Classification of Diseases, 9th Revision codes for 
procedure, inclusion and exclusion criteria for cholecystectomy.  
  
Procedure  
   Open cholecystectomy 51.21, 51.22   
   Laparoscopic cholecystectomy 51.23, 51.24  
  
Inclusion  
   Kidney transplant recipient: V42.0  
  
Exclusion  
   Other (non-kidney) transplant recipients: V42.1, V42.2, V42.6, V42.7, V42.8, V42.81, V42.82, 
V42.83, V42.84, V42.89, V42.9   
  Complications from history of other (non-kidney) transplant: 996.80, 996.82, 996.83, 996.84, 





Appendix D. International Classification of Diseases, 9th Revision codes for 
procedure, inclusion and exclusion criteria for colorectal resection.  
  
Procedure  
   Open and other partial excision of large intestine 45.7  
   Open and other multiple segmental resection of large intestine 45.71  
   Open and other cecectomy 45.72  
   Open and other right hemicolectomy 45.73  
   Open and other resection of transverse colon 45.74  
   Open and other left hemicolectomy 45.75  
   Open and other sigmoidectomy 45.76  
   Open and unspecified partial excision of large intestine 45.79  
   Total intra-abdominal colectomy 45.8  
   Colostomy 46.1  
   Other enterostomy 46.3  
   Revision of large intestinal stoma 46.5  
   Closure of large intestinal stoma 46.6  
   Other repair of large intestine 46.7  
   Dilation and manipulation of large intestine 46.8  
   Other operations on large intestines 46.9  
   Myotomy of sigmoid colon 46.91  
   Myotomy of other parts of colon 46.92  
   Revision of anastomosis of large intestine 46.94  
   Pull through resection of rectum 48.4  
   Abdominoperineal resection of rectum 48.5  
  
Inclusion  
   Kidney transplant recipient: V42.0  
  
Exclusion  
   Other (non-kidney) transplant recipients: V42.1, V42.2, V42.6, V42.7, V42.8, V42.81, V42.82, 
V42.83, V42.84, V42.89, V42.9   
  Complications from history of other (non-kidney) transplant: 996.80, 996.82, 996.83, 996.84, 





Appendix E. International Classification of Diseases, 9th Revision, clinical 
modification codes for postoperative in-hospital complications. Adapted from 
Guller et al.26 
  
Mechanical Wound  
   Delayed wound healing, 998.83  
   Postoperative hematoma, 998.12  
   Postoperative seroma (non-infected), 998.13  
   Disruption of operative wound, 998.3  
   Persistent postoperative fistula, 998.6  
Infectious  
   Postoperative infection, 998.5  
   Postoperative skin abscess, 998.59  
   Postoperative septic wound complications, 998.59  
   Postoperative skin infection, 998.59  
   Postoperative intraabdominal abscess, 998.59  
   Postoperative subdiaphragmatic abscess, 998.59  
   Postoperative infected seroma, 998.51  
Urinary  
   Postoperative urinary retention, 997.5  
   Postoperative urinary tract infection, 997.5  
Pulmonary  
   Postoperative atelectasis, 997.3   
   Postoperative pneumonia, 997.3   
   Postoperative acute respiratory insufficiency, 518.5   
   Postoperative acute pneumothorax, 512.1   
   Adult respiratory distress syndrome, 518.5   
   Postoperative pulmonary edema, 518.4  
Gastrointestinal tract   
   Postoperative small-bowel obstruction, 997.4   
   Postoperative ileus, 997.4   
   Postoperative ileus requiring nasogastric tube, 997.4   
   Postoperative nausea, 997.4   
   Postoperative vomiting, 997.4   
   Postoperative pancreatitis, 997.4   
   Complication of anastomosis of gastrointestinal tract, 997.4  
Cardiovascular   
   Postoperative deep venous thrombosis, 997.79   
   Postoperative pulmonary embolism, 415.11   
   Postoperative stroke, 997.02   
   Phlebitis or thrombophlebitis from procedure, 997.2   
   Cardiac arrest/insufficiency during or resulting from a procedure, 997.1  
Intraoperative   
  Accidental puncture or laceration, complicating surgery, 998.2   
  Foreign body accidentally left during procedure, 998.4   
  Hemorrhage/bleeding complicating procedure, 998.11  
  





_____________________________   __March 21, 2017__ 
Sandra Renae DiBrito, MD     
 
DEMOGRAPHIC AND PERSONAL INFORMATION 
 
Current Appointments  
2012-present Halsted General Surgery Resident, Johns Hopkins University 
2015-present Research Fellow, Johns Hopkins Bloomberg School of Public Health 
 
Personal Data 
Address  Johns Hopkins Hospital, Department of Surgery 
600 N. Wolfe St, Tower 110, Baltimore MD 21287 
Tel   970-409-8005 
E-mail  dibrito@jhmi.edu 
 
Education and Training  
2008 BS, Molecular Biology, minors in Chemistry, Mathematics, and Physics; 
summa cum laude, University of Denver/ Denver CO 
2012   MD, Medicine, Boston University School of Medicine / Boston MA 
2018 PhD candidate, Clinical Investigations, Johns Hopkins Bloomberg School 
of Public Health / Baltimore MD (primary mentors: Dorry Segev, MD 
PhD; Jacqueline Garonzik-Wang, MD PhD) 
2020   General surgery residency, Johns Hopkins University / Baltimore MD 
 
Professional Experience  
09/2004 – 08/2005 Research Assistant, University of Denver Department of Biology / Denver 
CO 
09/2004 – 08/2006 Greenhouse Manager, University of Denver Department of Biology / 
Denver CO 
06/2006 – 12/2007 Research Assistant, Eleanor Roosevelt Institute / Denver CO 
09/2007 – 08/2008 Tutor in Math, Chemistry, Biology, A+ Personal Tutoring / Denver CO 
09/2007 – 08/2008 Instructor, Kaplan MCAT Preparatory Program / Denver CO 
06/2009 – 08/2009 Extern in Reproductive Health, Family Care Medical Center / Denver CO 
07/2015 – present Course Instructor, Medical Student Surgery Clerkship, Johns Hopkins 
University / Baltimore MD 
 
PUBLICATIONS:  
Original Research [* denotes co-first authorship. Role in multi-authored articles is indicated as follows if not first or last 
author: C = concept design, D = data acquisition, A = analysis, W = drafting/writing, R = revision] 
1. McAdams-DeMarco MA, King EA, Luo X, Haugen C, DiBrito S, Schaffer A, Kucirka LM, 
Desai NM, Dagher NN, Lonze BE, Montgomery RA, Walston J, Segev DL. Frailty, Length 
of Stay, and Mortality in Kidney Transplant Recipients: A National Registry and Prospective 
Cohort Study. Annals of Surgery. 12.2017; 266(6):1084-1090 [WR] 
2. Hicks CW, DiBrito SR, Magruder JT, Weaver ME, Barenski CM, Heller J. Radiofrequency 
Ablation with Concomitant Stab Phlebectomy Increases Risk of Endothermal Heat Induced 
102 
 
Thrombosis: A Propensity-Matched Analysis. Journal of Vascular Surgery. 03.2017; 5(2):200-
209 [DAWR] 
3. Hicks CW, Liu J, Yang W, DiBrito S, Johnson DJ, Brito A, Higgins R, Frank SM, Wick E. 
A Resident-based choosing wisely quality improvement initiative to reduce unnecessary 
transfusions in an academic department of surgery. American Journal of Surgery. 10/2017. 
214(4):571-576.[CWR, SI/QI] 
4. Alejo J, Luo X, Massie AB, Henderson M, DiBrito S, Locke JE, Purnell T, Boyarsky B, 
Anjum S, Halpern S, Segev DL. Patterns of primary care utilization before and after living 
kidney donation. Clinical Transplantation. 07/2017; 31(7). [AWR] 
5. Chow EK, DiBrito S, Luo X, Wickliffe C, Massie AB, Locke JE, Gentry SE, Garonzik-
Wang J, Segev DL. Long cold ischemia times in same hospital deceased donor transplants. 
Transplantation. 09/2017. Epub ahead of print [CAWR] 
6. DiBrito SR*, Henderson ML*, Thomas AG, Holscher CM, Shaffer AA, Bowring MG, 
Purnell TS, Massie AB, Garonzik-Wang J, Waldram M, Lentine KL, Segev DL. Living Multi-
organ Donors in the United States. Transplantation. 01.2018; Epub ahead of print.  
7. DiBrito SR, Cerullo M, Goldstein S, Ziegfeld S, Stewart FD, Nasr I. Reliability of Glasgow 
Coma Score in Pediatric Trauma Patients. Journal of Pediatric Surgery. 01/2018. (In press) 
8. Van Pilsum Rasmussen S, Konel J, Warsame F, Ying H, Buta B, Haugen C, King E, DiBrito 
S, Varadhan R, Rodríguez-Mañas L, Walston J, Segev D, McAdams-DeMarco M. Engaging 
Clinicians and Patients to Assess and Improve Frailty Measurement in Adults with End 
Stage Renal Disease. BMC Nephrology. 01.2018. 19(1):8. [CDWR] 
9. DiBrito SR, Henderson ML. Should trauma surgeons treat a severely injured patient for the 
sake of elucidating preferences about organ donation? AMA Journal of Ethics. 2018. (in press). 
10. DiBrito SR, Jones C. What are the ethical implications of regionalization of trauma care? 
AMA Journal of Ethics. 2018. (in press). 
11. Holscher CM, Jackson K, Chow EK, Thomas AG, Haugen CE, DiBrito SR, Purcell C, 
Ronin M, Waterman AD, Garonzik-Wang J, Massie AB, Gentry SE, Segev DL. Kidney 
exchange match rates in a large multicenter clearinghouse. American Journal of Transplantation. 
2018. (in press) 
12. Jan S, Ragunanthan B, DiBrito SR, Omolabake A, Gutierrez MJ. Cefepime Efficacy and 
Safety in Children: A Systematic Review and Meta-Analysis. Frontiers in Pediatrics - Pediatric 
Infectious Diseases. 2018 (in press) [CDAWR]  
13. DiBrito SR, Olorundare IO, Holscher CM, Landazabal C, Orandi BJ, Dagher NN, Segev 
DL, Garonzik-Wang J. Surgical Approach, Cost, And Complications of Appendectomy in 
Kidney Transplant Recipients. Clinical Transplantation. 2018. (in press) 
 
Case Reports 
1. DiBrito SR, Stephens RS. Unpredictable Location of Central Line. JAMA Surg. 2014 Aug; 
149(8): 871-872.  
2. Ladd MR, Shaw K, Munoz-Blanco S, Gilmore M, DiBrito SR, Eloundou SN, Stevens K, 
Nasr IW, Stewart FD. A Case of a Gunshot Wound to the Fetus in Utero. Journal of Trauma 
and Acute Care Surgery. 2017 Apr; 82(4):814-816.  
 
Book Chapters, Monographs 
1. DiBrito SR and Duncan MD. (2016). Management of Small Bowel Obstruction. Cameron 
JL, Cameron AM (Eds): Current Surgical Therapy, 12e (Current Therapy). Philadelphia, PA: 
Elsevier Saunders. 
2. Blair AB, DiBrito SR, Duncan MD. (2018). Malignant Diseases of the Gallbladder and Bile 
Ducts. Rosenthal RA, Katlic MR, Zenilman ME (Eds): Principles and Practice of Geriatric 
Surgery, 3e New York, NY: Springer. 1-17. doi:10.1007/978-3-319-20317-1_71-1 
103 
 
3. DiBrito SR and Haut E. (2018). Interactions with Residents. Yoon-Flannery K, Fisher CS, 
Neff MA (Eds): A Surgeon’s Path: Navigating Your Career After a General Surgery 
Residency. New York, NY: Springer. In press 
Editorials 
1. DiBrito SR, Makary M. Forecasting Hospital Readmission After Surgery: Data and the 
Hard-to-Measure Role of Culture. JAMA Surg. 2014 May; 149(5): 445-446. 
2. DiBrito SR, Holscher CM, Haugen CE, Leeds I, Jackson K, Overton H, King E, Haut E. 
The Modern Surgeon Scientist. Annals of Surgery. 2017. (In press). 
3. Leeds I, DiBrito SR, Sacks B. How we measure surgical trainee performance matters. 
JAMA Surgery. 2017. (In press). 
 
FUNDING 
EXTRAMURAL Funding  
Current: 
07/2015 – 06/2018 “Health Care Utilization and Race: Live Kidney Donor Risks and 
Outcomes” 
Ruth L Kirschstein National Research Service Award, F32 
#F32DK105600   
NIDDK, NIH 
$221,970 
Principal Investigator, 95% effort 
08/2017 – 08/2018 “Using Financial Incentives to Increase Live Kidney Donor Follow-up 
Compliance” 
   Living Legacy Foundation Grant 
   $10,000 
   Co-investigator, grant writer, 5% effort 
   Jacqueline Garonzik-Wang MD PhD, PI 
Johns Hopkins University School of Medicine, Epidemiology Research 
Group in Organ Transplantation 
Previous: 
11/2005 –12/2005 Marsico Student Research Grant 
   Marsico Research Initiative 
   $2,500 
   Co-investigator, grant writer 
   Dennis Barrett PhD, PI 
Research Scholar at University of California, Bodega Bay Marine 
Laboratory 100% effort 
INTRAMURAL Funding  
Previous: 
11/2006 – 12/2006 Partners in Scholarship, Student Travel Grant 
   University of Denver 
   $1,500 
   Research Scholar at Oklahoma Medical Research Foundation 
Education Intramural Funding 
04/2017  Residents as Teachers and Leaders, Travel Grant 
   Johns Hopkins Hospital, Department of Surgery 
   $1,000 




SYSTEM INNOVATION AND QUALITY IMPROVEMENT ACTIVITIES 
 
System Innovation and Quality Improvement efforts within JHMI: 
06/2016 Team organizer QI project/1% effort; Johns Hopkins Department of Surgery, 
Recognizing Surgical Team Members, inpatient surgical units, results: trending 
patient satisfaction with recognizing providers on their surgical teams following 
distribution of “face sheets” indicating team members and their roles.  
 
System Innovation and Quality Improvement Program Building/Leadership: 
01/2016 – 07/2017 General Surgery Representative/1% effort; House Staff Patient Safety and 
Quality Council, 2016 project: Sepsis Bundle Compliance, 1 hour monthly 
meeting and outside activities 
 
10/2016 Institutional Representative, Residents Leading Quality Course at American 
College of Surgeons National Meeting, 8 hour course on performing quality 
improvement projects  
 
ORGANIZATIONAL ACTIVITIES  
 
Journal peer review activities    
1/2017  Trauma Surgery & Acute Care Open, junior reviewer under Elliott Haut MD PhD 
Administrative Appointments  
2012 - 2018 Representative, General Surgery Residency Review Committee, Johns Hopkins 
Hospital 
2013 - 2015 Director, Zayed Workroom Improvement Workgroup, Johns Hopkins Hospital 
2013 - 2017 Leader, Surgery Department Spirit Campaign, Johns Hopkins Hospital 
2013 - present Interviewer, General Surgery Residency Admissions Committee, Johns Hopkins 
Hospital 
2016 Member, Sentinel Event Root Cause Analysis Team (retained foreign body), Johns 
Hopkins Hospital 
2017 Member, Joy in Medicine Working Group on Clinical and Academic Success, Johns 
Hopkins Hospital 
2018 Member, Multicenter Trials Committee, Eastern Association for the Surgery of 
Trauma 
Professional Societies  
08/2012 – present American College of Surgeons, resident member 
09/2015 – present Association of Academic Surgeons, resident member 
09/2015 – present American Society of Transplant Surgeons, resident member 
03/2016 – present Association of Women Surgeons, resident member 
05/2016 – present Pediatric Trauma Society, member 
01/2017 – present Eastern Association for the Surgery of Trauma, provisional member 
Conference Organizer  
5/14/2016 “Spotlight on Gastric Cancer”, No Stomach for Cancer National Meeting, 
Johns Hopkins Hospital, Local team leader 
 
RECOGNITION  
Awards, Honors  
2004 – 2007 Chancellor’s Scholarship 
2004 – 2007 Leda B. Schwartz Scholar, Biological Sciences 
105 
 
2004 – 2007 University of Denver Honors Program 
2006, 2007 Stczyen Premedical Scholarship 
2007  Phi Beta Kappa (inducted as a junior, selected as induction speaker) 
2011  Gold Humanism Honor Society 
2016, 2017 Poster of Distinction, Academic Transplant Congress 
2016  Distinguished Teaching Society of Johns Hopkins School of Medicine 
2017 Mark M. Ravitch Award for Scientific Writing, Dept of Surgery, Johns Hopkins 
Hospital 
2017  Top Paper Award, Association of Women Surgeons & American Journal of Surgery  
 
Invited Talks  
JHMI/Regional 
09/28/2016, 09/25/2017 
 “Things We Put In People: A Primer on Lines and Tubes”,  Johns Hopkins 
Department of Pediatrics, noon conference, 1 hour lecture to pediatric residents, 
attendings, and medical students discussing types of venous lines and various tubes 
to increase familiarity and improve interactions with pediatric surgery consult team   
National 
08/04/2017 “Near Peer Panel”, KUH Summer Undergraduate Research Conference, NIH, 
Bethesda MD; panelist for 1 hour 30min session on pursuing careers in research, 
attended by appx 100 students and NIH faculty. 
08/04/2017 Moderator for poster session at KUH Summer Undergraduate Research 
Conference, NIH, Bethesda MD 
 
 
OTHER PROFESSIONAL ACCOMPLISHMENTS  
Oral/Podium Presentations  
1. DiBrito SR. Barrett D. Environmental and genetic control of cell organization and 
locomotion in early developmental stages of sea urchin. 2006 Marsico Research Initiative 
Symposium, University of Denver, Denver CO, 02/2006. 
2. DiBrito SR, Olorundare IO, Landazabal CS, Segev DL, Dagher NN. Outcomes following 
appendectomy in kidney transplant recipients. 2016 Academic Surgical Congress, 
Jacksonville FL, 02/2016. 
3. DiBrito SR, Olorundare IO, Landazabal CS, Segev DL, Dagher NN. Outcomes following 
inguinal hernia repair in kidney transplant recipients. 2016 American Transplant Congress, 
Boston MA, 06/2016. 
4. Hicks CW, Magruder JT, Weaver ML, DiBrito SR, Barenski C, Heller JA. Radiofrequency 
ablation with concomitant stab phlebectomy increases risk of endothermal heat induced 
thrombosis: a propensity matched analysis. 2016 Vascular Annual Meeting, Washington DC 
06/2016.  
5. DiBrito SR, Cerullo M, Goldstein S, Ziegfeld S, Stewart FD, Nasr I. Discrepancy between 
on-scene and ED GCS in pediatric trauma patients. 2016 American College of 
Surgeons/Maryland Committee on Trauma Resident Paper Competition, Baltimore MD, 
11/2016. 
6. DiBrito SR, Cerullo M, Goldstein S, Ziegfeld S, Stewart FD, Nasr I. How reliable is GCS in 
Pediatric Trauma? 2016 Pediatric Trauma Society National Meeting, Nashville TN, 11/2016. 
7. Cerullo M, DiBrito SR, Goldstein S, Ziegfeld S, Stewart FD, Nasr I. How does 
implementing strict triage criteria for helicopter transport affect outcomes? 2016 Pediatric 
Trauma Society National Meeting, Nashville TN, 11/2016. 
106 
 
8. Cerullo M, DiBrito SR, Goldstein S, Ziegfeld S, Stewart FD, Nasr I. Drivers of the 
geographic distribution of pediatric burns. 2016 Pediatric Trauma Society National Meeting, 
Nashville TN, 11/2016. 
9. DiBrito SR, Holscher CM, Olorundare IO, Haugen CH, Alimi Y, Segev DL, Garonzik-
Wang J. Outcomes following cholecystectomy in kidney transplant recipients. 2017 
Academic Surgical Congress, Las Vegas NV, 02/2017. 
10. Hicks CW, Liu J, Yang W, DiBrito SR, Johnson DJ, Brito A, Higgins R, Frank SM, Wick E. 
A Resident-based choosing wisely quality improvement initiative to reduce unnecessary 
transfusions in an academic department of surgery. 2017 Association of Women Surgeons 
Paper Competition, San Diego CA, 10/2017 (presenter). 
11. Leeds IL, DiBrito SR, Jones C, Haut E. Assessing learning during morbidity and mortality 
conference with a real-time audience response system. 2017 American College of Surgeons, 
San Diego CA 10/2017. 
12. DiBrito SR, Bowring MG, Rasmussen S, Haugen CE, Holscher CM, Zonnenberg N, 
Henderson M, Segev DL, Garonzik-Wang J. Performing General Surgery on Transplant 
Recipients: A Pilot Survey on Surgeon Perspectives. 2017 American College of 
Surgeons/Maryland Committee on Trauma Resident Paper Competition, Baltimore MD, 
11/2017. 
13. DiBrito SR*, Craig-Schapiro R*, Overton H, Taylor J, Fransman R, Haut E, Sacks B. Meet 
your Surgical Team: The Impact of a Facesheet on Patient Satisfaction. 2018 Academic 
Surgical Congress, Jacksonville FL 01/2018[SI/QI] 
Posters 
1. DiBrito SR, Hochgeschwender U. a-MSH expression in corticotrophs of the anterior 
pituitary. 2007 University of Denver Undergraduate Research Symposium, Denver CO 
05/2007. 
2. Cheng A, Carnegie D, DiBrito SR, Choti MA. Sterile manipulation image viewer in the 
Operating Room. 2013 Johns Hopkins Imaging Conference, Baltimore MD, 11/2013. 
(presenter) 
3. Bae S, Durand C, Kucirka L, DiBrito SR, Avery R, Garonzik-Wang J, Segev DL. Early 
Steroid Withdrawal and Infection in Kidney Transplant Recipients. 2016 American Society 
of Transplant Surgeons Winter Meeting, Miami FL, 02/2016; 2017 American Transplant 
Congress, Chicago IL, 04/2017. 
4. DiBrito SR, King EA, O’hare M, Segev DL. Socioeconomic status and readmission 
following kidney transplant. 2016 American Society of Transplant Surgeons Winter Meeting, 
Miami FL, 02/2016 
5. Dagher NN, DiBrito SR, Olorundare IO, Landazabal CS, Segev DL. Outcomes following 
appendectomy in liver transplant recipients. 2016 American Transplant Congress, Boston 
MA, 06/2016. (presenter) 
6. Dagher NN, DiBrito SR, Olorundare IO, Landazabal CS, Segev DL. Outcomes following 
inguinal hernia repair in liver transplant recipients. 2016 American Transplant Congress, 
Boston MA, 06/2016. (presenter) 
7. DiBrito SR, Olorundare IO, Landazabal CS, Segev DL, Dagher NN. Outcomes following 
inguinal hernia repair in patients with end stage liver disease. 2016 American Transplant 
Congress, Boston MA, 06/2016. 
8. DiBrito SR, Holscher CM, Olorundare IO, Haugen CH, Alimi Y, Segev DL, Garonzik-
Wang J. Outcomes following cholecystectomy in kidney transplant recipients. 2017 
American Society of Transplant Surgeons Winter Meeting, Miami FL, 01/2016. 
9. DiBrito SR, Holscher CM, Olorundare IO, Haugen CH, Alimi Y, Segev DL, Garonzik-
Wang J. Outcomes following cholecystectomy in kidney transplant recipients. 2017 
American Society of Transplant Surgeons Winter Meeting, Miami FL, 01/2016. 
107 
 
10. DiBrito SR, Alimi Y, Holscher CM, Olorundare IO, Garonzik-Wang J, Segev DL. The cost 
of colectomy after kidney transplantation. 2017 American Society of Transplant Surgeons 
Winter Meeting, Miami FL, 01/2016. 
11. Cerullo M, Goldstein S, DiBrito SR, Noje C, Ziegfield S, Stewart FD, Robertson C, Jackson 
E, Nasr I. A predictive model for improved disposition of pediatric traumatic brain injury 
patients. 2017 American Pediatric Surgery Association, Hollywood FL, 05/2017. 
12. Leeds I, Canner J, Gearhart S, DiBrito SR, Efron J, Fang S, Safar B. Extended 
venothromboembolism prophylaxis after colorectal cancer surgery is not justified without 
further risk stratification. 2017 American Society of Colon and Rectal Surgeons Annual 
Scientific Meeting, Seattle WA, 06/2017.  
13. Rasmussen S, Konel J, Ying H, Haugen C, King E, DiBrito S, Segev D, McAdams-
DeMarco M. Engaging Clinicians and Patients Regarding Frailty Assessment in Kidney 
Transplant Candidates. 2017 American Transplant Congress, Chicago IL, 04/2017. 
14. Bae S, Durand C, Kucirka L, DiBrito S, Avery R, Garonzik-Wang J, Segev D. Trends in 
Infection Among Kidney Transplant Recipients, 1999-2013. 2017 American Transplant 
Congress, Chicago IL, 04/2017. 
15. Holscher CM, Henderson ML, DiBrito SR, Thomas AG, Shaffer AA, Bowring MG, Purnell 
TS, Massie AB, Garonzik Wang J, Waldram M, Lentine KL, Segev DL. Living Multi-organ 
Donors in the United States: What Do We Know? 2017American College of Surgeons 
Clinical Congress, San Diego CA. 10/2017. 
16. DiBrito SR, Bowring MG, Rasmussen S, Haugen CE, Holscher CM, Zonnenberg N, 
Henderson M, Segev DL, Garonzik-Wang J. Who Should Operate on Transplant 




2004-2005 Volunteer, Denver Botanical Gardens, 1hr per week / Denver CO 
2006-2007 Volunteer, St. Anthony’s Hospital, Department of OBGYN, 3hrs per week / 
Denver CO 
2006 - 2012 Producer, director, cast member of The Vagina Monologues at University of 
Denver, Boston University School of Medicine; raised over $25,000 for women’s 
charities 
10/18/2016 Volunteer, Medical Student Mock Interviews, American College of Surgeons, 2 
hours / Washington DC 







Dr. Sandra R. DiBrito was born on June 29, 1986 in Pueblo, Colorado, and raised in 
Silverthorne, Colorado. She was the valedictorian of Summit High School, Class of 2004. 
She attended the University of Denver on a Chancellor’s scholarship, where she 
participated in the University Honors program. She conducted basic science research at 
the Eleanor Roosevelt Institute under the guidance of Dr. Miles Brennan and wrote her 
undergraduate thesis on the pro-opiomelanocortin gene and its products in a mouse 
model.  She graduated summa cum laude in 2007 with a B.S. in Molecular Biology and 
minors in Chemistry, Mathematics, and Physics. She pursued medical school at Boston 
University School of Medicine, and outside of her coursework, produced and directed 
four annual performances of The Vagina Monologues, raising over $25,000 for women’s 
charities in Boston. In 2012, she began her General Surgery residency at The Johns 
Hopkins Hospital. After receiving a National Institute of Health Ruth L. Kirschstein F32 
National Research Service Award, she joined the Epidemiology Research Group in 
Organ Transplantation, led by Dr. Dorry Segev, to pursue her PhD in Clinical 
Investigations at the Johns Hopkins Bloomberg School of Public Health. Dr. DiBrito was 
inducted into the inaugural class of the Distinguished Teaching Society of the Johns 
Hopkins School of Medicine in 2016, and during her time in the research lab, she 
participated weekly in medical student education as a Halsted Teaching Resident. After 
completing her clinical training, she plans to pursue a fellowship in trauma and acute 
care surgery. In her free time, Dr. DiBrito enjoys being outdoors, traveling, and spending 
time with her two sons, Maxwell and Franklin, her wife, Kate, and her dog, Violet.   
